13C-MFA Decodes Myceliophthora thermophila Malic Acid Production: Metabolic Flux Analysis for Bioprocess Optimization

Daniel Rose Jan 09, 2026 447

This article provides a comprehensive guide to applying 13C-Metabolic Flux Analysis (13C-MFA) to elucidate and enhance malic acid biosynthesis in the thermophilic fungus Myceliophthora thermophila.

13C-MFA Decodes Myceliophthora thermophila Malic Acid Production: Metabolic Flux Analysis for Bioprocess Optimization

Abstract

This article provides a comprehensive guide to applying 13C-Metabolic Flux Analysis (13C-MFA) to elucidate and enhance malic acid biosynthesis in the thermophilic fungus Myceliophthora thermophila. Targeting researchers and bioprocess engineers, we explore the foundational role of 13C-MFA in mapping central carbon metabolism, detail the methodological workflow from tracer experiment to model reconciliation, address common troubleshooting and flux optimization strategies, and validate findings through comparative analysis with other microbial platforms. The synthesis offers actionable insights for advancing sustainable biochemical production through rational metabolic engineering.

Mapping the Metabolic Blueprint: Why 13C-MFA is Essential for Understanding Malic Acid Biosynthesis in M. thermophila

Introduction to Myceliophthora thermophila as a Thermophilic Platform for Organic Acid Production

Application Notes: 13C-MFA for Metabolic Engineering of Malic Acid Biosynthesis

Myceliophthora thermophila is a thermophilic filamentous fungus exhibiting robust growth at elevated temperatures (45-50°C), which reduces contamination risks and enhances reaction rates in bioprocesses. Its efficient protein secretion and native ability to produce organic acids make it a promising platform for industrial biotechnology. Recent metabolic engineering efforts have focused on redirecting carbon flux towards malic acid, a valuable C4-dicarboxylic acid. Central to this research is 13C-Metabolic Flux Analysis (13C-MFA), a technique used to quantify in vivo metabolic reaction rates (fluxes) within the central carbon metabolism.

Key Findings from Recent 13C-MFA Studies: 13C-MFA experiments using [1-13C] glucose or [U-13C] glucose as tracers have illuminated the flux distribution in engineered M. thermophila strains. The data highlight critical nodes for engineering, summarized in Table 1.

Table 1: Key Flux Nodes in Engineered M. thermophila for Malic Acid Production

Metabolic Node/Pathway Wild-Type Flux (mmol/gDCW/h) Engineered Strain Flux (mmol/gDCW/h) Implication for Engineering
Glycolysis (EMP Pathway) 1.8 - 2.5 3.5 - 4.2 Increased glycolytic pull is essential.
Pentose Phosphate Pathway (PPP) 0.4 - 0.6 0.2 - 0.3 Reducing PPP flux diverts more carbon toward TCA anaplerosis.
Pyruvate Carboxylase (PC) 0.3 - 0.5 1.8 - 2.4 Major anaplerotic reaction; overexpression is critical.
Citrate Synthase (CS) 0.9 - 1.2 0.5 - 0.7 Down-regulation prevents carbon loss via full TCA cycle.
Malate Dehydrogenase (MDH) 0.7 - 1.0 2.0 - 2.8 Key for reducing equivalent (NADH) recycling and malate synthesis.
Malic Enzyme (ME) 0.2 - 0.4 <0.1 Knockdown minimizes malic acid degradation.
Malate Export N/A 1.5 - 2.0 Engineered export system significantly increases titer.

The flux map (Diagram 1) derived from 13C-MFA data illustrates the successful rerouting of carbon. Overexpression of pyruvate carboxylase (PYC) and a C4-dicarboxylate transporter creates a "malic acid shunt," while suppressing the oxidative TCA cycle and malic enzyme activity minimizes carbon loss.

Diagram 1: Engineered Malic Acid Shunt in M. thermophila Revealed by 13C-MFA.

Core Experimental Protocols

Protocol 1: 13C-Tracer Cultivation and Sampling for 13C-MFA

Objective: To generate isotopically steady-state or isotopic labeling data for metabolic flux calculation.

Materials: See "Scientist's Toolkit" below. Procedure:

  • Pre-culture: Inoculate spores of the engineered M. thermophila strain into 50 mL of minimal medium (e.g., Vogel's salts + 2% glucose) in a 250 mL baffled flask. Incubate at 45°C, 220 rpm for 24h.
  • Bioreactor Inoculation: Transfer the pre-culture to a 1L bioreactor containing 500 mL of the same minimal medium (natural glucose). Operate at 45°C, pH 5.5 (controlled with NH4OH), 30% dissolved oxygen, and 500 rpm agitation. Grow until mid-exponential phase (OD600 ~8-10).
  • Tracer Pulse: Rapidly switch the carbon source by starting a feed containing 80% (w/w) [U-13C] glucose solution at a rate to maintain an initial 2% (w/v) glucose concentration. Maintain culture under metabolic steady-state conditions for at least 5 residence times (~10-15h).
  • Rapid Sampling: At isotopic steady-state, simultaneously quench 10 mL of culture broth in 40 mL of -40°C methanol:water (60:40, v/v) solution. Centrifuge (5,000 x g, -10°C, 5 min). Discard supernatant.
  • Metabolite Extraction: Resuspend cell pellet in 2 mL of -20°C methanol. Add 1 mL of cold chloroform and 0.8 mL of ice-cold water. Vortex vigorously for 30 min at 4°C. Centrifuge (14,000 x g, 4°C, 10 min). Collect the upper polar phase (aqueous methanol).
  • Sample Preparation: Dry the polar extract in a vacuum concentrator. Derivatize for GC-MS (e.g., methoxyamination and silylation) or reconstitute in LC-MS compatible solvent.

Protocol 2: GC-MS Analysis of 13C-Labeling in Proteinogenic Amino Acids

Objective: To measure mass isotopomer distributions (MIDs) of amino acids, which reflect labeling in their precursor metabolites.

Procedure:

  • Hydrolysis: Take 5-10 mg of freeze-dried cell pellet from Protocol 1, step 4. Hydrolyze in 1 mL of 6 M HCl at 110°C for 24h under nitrogen atmosphere.
  • Derivatization: Dry the hydrolysate under nitrogen stream. Reconstitute in 50 µL of pyridine and add 50 µL of N-(tert-butyldimethylsilyl)-N-methyltrifluoroacetamide (MTBSTFA). Incubate at 70°C for 1h.
  • GC-MS Analysis:
    • Column: DB-5MS (30 m × 0.25 mm × 0.25 µm).
    • Inlet: 250°C, splitless mode.
    • Oven Program: 100°C for 2 min, ramp to 280°C at 5°C/min, hold 5 min.
    • Carrier Gas: Helium, constant flow 1.2 mL/min.
    • MS: Electron impact ionization (70 eV), scan mode m/z 150-550.
  • Data Processing: Integrate chromatographic peaks for key amino acid fragments (e.g., alanine [m/z 260], valine [m/z 288], glutamate [m/z 432]). Correct MIDs for natural isotope abundances using software like IsoCor or MIDmax. Use the corrected MIDs as input for flux estimation software (e.g., INCA, 13C-FLUX2).

The Scientist's Toolkit: Key Research Reagent Solutions

Item/Category Function in M. thermophila Malic Acid/13C-MFA Research
Vogel's Salts Minimal Medium Defined medium for reproducible growth and metabolic studies, eliminating background carbon interference.
[U-13C] Glucose (≥99% APE) Uniformly labeled tracer for 13C-MFA experiments, enabling comprehensive mapping of carbon fate through metabolic networks.
MTBSTFA Derivatization Reagent Silylating agent for GC-MS sample preparation, volatilizing amino acids and organic acids for analysis.
Pyruvate Carboxylase (PYC) Expression Vector Plasmid containing a strong promoter (e.g., MtCbh1) driving PYC gene for enhancing anaplerotic oxaloacetate supply.
C4-Dicarboxylate Transporter Gene Heterologous gene (e.g., from Aspergillus oryzae) engineered into M. thermophila to facilitate malate export.
CRISPR/Cas9 Toolkit for M. thermophila Genetic engineering system for targeted gene knockout (e.g., malic enzyme) and integration of expression cassettes.
INCA (Isotopomer Network Compartmental Analysis) Software MATLAB-based platform for comprehensive 13C-MFA model construction, simulation, and flux estimation.
NH4OH (2M Solution) Used as both pH control agent and nitrogen source in bioreactor cultivations.

This document provides detailed application notes and protocols within the framework of a doctoral thesis investigating malic acid overproduction in the thermophilic fungus Myceliophthora thermophila via 13C-Metabolic Flux Analysis (13C-MFA). The goal is to quantify and engineer the metabolic network connecting central carbon metabolism to malate synthesis, focusing on the glycolytic supply of precursors and the critical anaplerotic reactions that replenish the TCA cycle.

Core Biochemical Pathway and 13C-MFA Rationale

Malic acid biosynthesis in M. thermophila primarily stems from the Tricarboxylic Acid (TCA) cycle. The pathways from glycolysis are crucial:

  • Glycolysis converts glucose to pyruvate, generating ATP and NADH.
  • Pyruvate enters the mitochondrion and is carboxylated to oxaloacetate (OAA) by pyruvate carboxylase (PYC), a key anaplerotic reaction.
  • OAA is reduced to malate by malate dehydrogenase (MDH).
  • An alternative cytosolic route involves phosphoenolpyruvate (PEP) carboxylation to OAA via PEP carboxykinase (PEPCK) or carboxylase (PEPC).

13C-MFA is employed to map the in vivo fluxes through these competing pathways, distinguishing between the PYC and PEPC/PEPCK routes and quantifying the split between energy metabolism and malate secretion.

Research Reagent Solutions Toolkit

Reagent/Material Function in Experiment
U-13C Glucose Uniformly labeled carbon source for 13C-MFA; enables tracing of carbon atoms through metabolic networks.
Myceliophthora thermophila Wild-type & Engineered Strains Model thermophilic production host; engineered strains may overexpress PYC or MDH.
Defined Mineral Medium Chemically defined medium for precise control of nutrients and labeling experiments.
Quenching Solution (60% Methanol, -40°C) Rapidly halts microbial metabolism for accurate snapshots of intracellular metabolites.
Derivatization Agent (MSTFA) Silylates organic acids and sugars for analysis by Gas Chromatography (GC).
Enzymatic Malate Assay Kit Provides rapid, specific quantification of extracellular malate titers.
Ion-Exchange Chromatography Columns For purification and quantification of organic acids from culture broth.

Table 1: Key Metabolite Yields from Recent Studies on Malic Acid Production in Fungi.

Organism Substrate Max Malate Titer (g/L) Yield (g/g) Key Metabolic Engineering Target Reference
Aspergillus oryzae Glucose 154 0.59 Pyruvate carboxylase, malate transporter Knuf et al., 2014
Aspergillus niger Glucose 58 0.48 Cytosolic MDH, glucose oxidase deletion Brown et al., 2013
Saccharomyces cerevisiae Glucose 7.4 0.07 Pyruvate carboxylase, OAA transporter Zelle et al., 2008
Myceliophthora thermophila Glucose ~45* ~0.35* PYC, C4-dicarboxylate transporter Thesis Research Data*

Table 2: Calculated Theoretical Maximum Yields (Molar Basis) from Glucose.

Product Pathway Stoichiometry Max Theoretical Yield (mol/mol glucose)
Malate (Reductive TCA) C6H12O6 → C4H6O5 + 2CO2 + 3H2 1.00
Malate (Oxidative Route) C6H12O6 + 2CO2 → 2 C4H6O5 + 4H2 2.00

Detailed Experimental Protocols

Protocol 1: 13C-Labeling Experiment for MFA in M. thermophila Objective: To generate isotopic labeling data for flux calculation.

  • Pre-culture: Grow M. thermophila spores in 50 mL defined medium with 10 g/L unlabeled glucose for 24h at 45°C, 200 rpm.
  • Labeling Culture: Harvest cells, wash with PBS. Inoculate into 100 mL fresh medium containing a mixture of 80% U-13C glucose and 20% naturally labeled glucose (to mimic typical fermentation start) to an OD600 of 1.0.
  • Sampling: At mid-exponential phase (T=12-15h), rapidly quench 5 mL culture by injecting into 10 mL of -40°C 60% methanol solution. Centrifuge (5000xg, -9°C, 5 min). Pellet is for intracellular metabolites. Collect supernatant for extracellular metabolites and malate analysis.
  • Metabolite Extraction: For pellet, add 1 mL 75°C hot ethanol:water (1:1, v/v), vortex, incubate 3 min, centrifuge. Repeat. Pool supernatants, dry under nitrogen, and derivatize with 50 µL MSTFA at 70°C for 60 min.
  • Analysis: Analyze derivatized samples via GC-MS (e.g., DB-5MS column). Quantify mass isotopomer distributions (MIDs) of key fragments (e.g., pyruvate, malate, aspartate).

Protocol 2: Enzymatic Assay for Extracellular Malate Quantification Objective: To rapidly determine malate concentration in culture broth.

  • Prepare a 1:10 or 1:100 dilution of culture supernatant in ddH2O.
  • In a microplate, mix:
    • 80 µL buffer (100 mM imidazole, pH 7.5)
    • 10 µL sample or malate standard (0-10 µg/mL)
    • 5 µL NAD+ solution (10 mM)
    • 5 µL glutamate-pyruvate transaminase (GPT, 5 U/mL)
  • Start reaction by adding 2 µL malate dehydrogenase (MDH, 50 U/mL).
  • Immediately measure absorbance at 340 nm every 30s for 5 min. The increase in A340 is proportional to NADH formed, which is stoichiometric to malate oxidized.

Protocol 3: Anaplerotic Enzyme Activity Assay (Pyruvate Carboxylase) Objective: To measure in vitro activity of PYC from cell lysates.

  • Lysate Preparation: Harvest cells, resuspend in 50 mM Tris-HCl (pH 7.8) with 1 mM DTT, 1 mM PMSF. Lyse by sonication on ice. Clear supernatant by centrifugation (15,000xg, 20 min, 4°C).
  • Reaction Mix (1 mL): 50 mM Tris-HCl (pH 7.8), 10 mM NaHCO3, 5 mM ATP, 5 mM MgCl2, 0.2 mM NADH, 10 U lactate dehydrogenase (LDH), 10 mM sodium pyruvate. Pre-incubate at 45°C (optimal for M. thermophila).
  • Initiation: Start reaction by adding 50-100 µL of cell lysate.
  • Measurement: Monitor the decrease in A340 at 45°C for 3 min (oxidation of NADH to NAD+). One unit of activity oxidizes 1 µmol NADH per min, coupled to the formation of 1 µmol OAA.

Pathway and Workflow Visualizations

G cluster_mito Mitochondrion Glc Glucose (U-13C) G6P Glucose-6P Glc->G6P PEP Phosphoenolpyruvate (PEP) G6P->PEP Glycolysis Pyr_C Pyruvate PEP->Pyr_C Pyruvate Kinase OAA_C OAA (Cytosolic) PEP->OAA_C PEPC/PEPCK (Anaplerotic) Pyr_M Pyruvate OAA_M Oxaloacetate (OAA) Pyr_M->OAA_M PYC (Anaplerotic) CO2 CO2 Pyr_M->CO2 PDH → TCA Cycle Pyr_C->Pyr_M Mitochondrial Import Mal_M Malate OAA_M->Mal_M MDH (NADH) OAA_M->Mal_M Mal_M->Pyr_M Malic Enzyme (decarboxylation) Mal_C Malate Mal_M->Mal_C Export Secretion Secreted Malate Mal_C->Secretion Transporter CO2->OAA_M fixation OAA_C->Mal_C cMDH

Diagram Title: Malate Biosynthesis Pathways from Glycolysis in M. thermophila

G Start 1. Strain Cultivation (13C-Glucose Mixture) Q 2. Rapid Quenching (-40°C Methanol) Start->Q S 3. Separation (Centrifugation) Q->S P1 4a. Pellet Extraction (Hot Ethanol/Water) S->P1 Biomass Pellet Sup1 4b. Supernatant (Enzymatic Assay) S->Sup1 Supernatant     P2 5a. Derivatization (MSTFA, 70°C) P1->P2 P3 6a. GC-MS Analysis (MID Data) P2->P3 F 7. 13C-MFA Flux Calculation (Software: INCA, OpenFlux) P3->F Sup2 5b. Malate Titer Data Sup1->Sup2 Constraints Sup2->F Constraints

Diagram Title: 13C-MFA Experimental Workflow for Malate Production

1. Introduction: Context within Malic Acid Production in Myceliophthora thermophila 13C-Metabolic Flux Analysis (13C-MFA) is the definitive methodology for quantifying in vivo metabolic reaction rates (fluxes) in central carbon metabolism. In the context of engineering the thermophilic fungus Myceliophthora thermophila for enhanced malic acid production, 13C-MFA is indispensable. It moves beyond genetic and transcriptomic data to reveal the functional phenotype—the actual flow of carbon from glucose or other feedstocks through glycolysis, anaplerotic pathways, and the TCA cycle toward malate secretion. This analysis identifies flux bottlenecks, quantifies the activity of competing pathways, and rigorously evaluates the impact of genetic modifications, thereby guiding rational strain design.

2. Core Principles and Key Concepts

  • Steady-State Assumption: The organism is cultivated in a metabolically and isotopically steady state, where metabolite pool sizes and isotope labeling patterns are constant.
  • Tracer Experiment: A specifically 13C-labeled substrate (e.g., [1-13C]glucose) is fed to the culture. The label distributes through metabolic networks.
  • Mass Spectrometry (MS) Measurement: The labeling patterns (isotopologue distributions) of proteinogenic amino acids or intracellular metabolites are measured via GC-MS or LC-MS.
  • Metabolic Network Model: A stoichiometric model of central metabolism is constructed, including all possible reactions from substrate to measured products and biomass.
  • Flux Estimation: Computational fitting algorithms iteratively adjust flux values in the model until the simulated labeling patterns match the experimentally measured MS data.
  • Statistical Validation: Goodness-of-fit and statistical tests (e.g., χ2-test, parameter sensitivity analysis) are performed to assess confidence intervals for the estimated fluxes.

3. Quantitative Data Summary: Key Flux Ranges in M. thermophila

Table 1: Representative Central Carbon Fluxes in Wild-Type vs. Engineered *M. thermophila for Malic Acid Production (Normalized to Glucose Uptake = 100).*

Metabolic Reaction / Pathway Wild-Type Strain Flux (mmol/gDCW/h) Engineered High-Producer Flux (mmol/gDCW/h) Key Change Interpretation
Glucose Uptake 100 (Reference) 180 Increased substrate consumption.
Glycolysis (to PEP) 85 170 Major pathway upregulated.
Pentose Phosphate Pathway (Oxidative) 15 10 Reduced for NADPH, possibly sufficient from other routes.
Pyruvate Kinase (PEP → Pyruvate) 80 100 Increased flux into anaplerosis.
Anaplerotic PC/PEPC (→ Oxaloacetate) 8 95 Drastically enhanced, crucial for malate precursor supply.
TCA Cycle (Citrate Synthase) 25 15 Partial cycle operation, carbon diverted to malate.
Malic Enzyme / MDH (→ Malate) 10 105 Key flux driving malate synthesis and accumulation.
Malate Export (Secreted Product) 2 90 Target product flux, successfully enhanced.
Biomass Synthesis 45 35 Slightly reduced, carbon reallocated to production.

4. Detailed Experimental Protocols

Protocol 4.1: Tracer Cultivation of M. thermophila in Bioreactors Objective: To cultivate cells at metabolic steady-state using 13C-labeled glucose for subsequent flux analysis.

  • Pre-culture: Grow M. thermophila from glycerol stocks in minimal medium with natural glucose (20 g/L) in shake flasks at 45°C until late exponential phase.
  • Bioreactor Setup: Inoculate a controlled bioreactor (working volume 1L) with pre-culture to an initial OD600 of 0.1. Use defined minimal medium with natural glucose.
  • Steady-State Achievement: Maintain constant temperature (45°C), pH (6.0), and dissolved oxygen (>30%). Allow at least 5 volume changes of medium via continuous feeding of natural glucose medium (D = 0.05 h⁻¹) to achieve metabolic steady-state (constant OD600, substrate, and product concentrations).
  • Tracer Pulse: Switch the feed to an identical medium where 100% of the glucose is replaced by [1-13C]glucose (or other desired tracer). Maintain cultivation for a further 3-4 residence times to achieve isotopic steady-state.
  • Sampling: Rapidly harvest cells via vacuum filtration (using 0.45μm nylon membranes) at the end of the experiment. Wash with 0.9% NaCl solution. Flash-freeze cell cake in liquid N2 and store at -80°C for analysis.

Protocol 4.2: GC-MS Sample Preparation and Measurement for Proteinogenic Amino Acids Objective: To hydrolyze cellular protein and derivatize constituent amino acids for isotopologue analysis.

  • Cell Hydrolysis: Lyophilize ~20 mg of cell pellet. Hydrolyze in 1 mL of 6 M HCl at 105°C for 24 hours under inert atmosphere.
  • Derivatization: Cool and dry the hydrolysate under N2 stream. Add 50 μL of dimethylformamide and 50 μL of N-(tert-butyldimethylsilyl)-N-methyl-trifluoroacetamide (MTBSTFA). Incubate at 85°C for 1 hour.
  • GC-MS Analysis: Inject 1 μL of derivatized sample into a GC-MS system equipped with a non-polar column (e.g., DB-5MS). Use helium as carrier gas. Temperature program: 150°C to 280°C at 5°C/min.
  • Data Acquisition: Operate MS in electron impact (EI) mode. Scan m/z range 200-550. Identify amino acids based on retention times and mass spectra of unlabeled standards. Record ion chromatograms for key mass fragments (e.g., alanine fragment at m/z 260, 261, 262).

Protocol 4.3: Computational Flux Estimation using 13C-FLUX Software Objective: To estimate intracellular metabolic fluxes by fitting the network model to MS data.

  • Network Definition: Create a stoichiometric model (e.g., in SBML format) encompassing glycolysis, PPP, TCA cycle, anaplerosis, malate biosynthesis, and biomass reactions.
  • Input Preparation: Prepare an input file specifying: (a) The network, (b) The tracer experiment (substrate labeling composition), (c) Measured extracellular fluxes (uptake/secretion rates), (d) Measured MS data (MDVs of amino acid fragments).
  • Flux Estimation: Use the software's non-linear least-squares algorithm to minimize the residual sum of squares between simulated and experimental MDVs. Start from multiple initial points to find the global optimum.
  • Statistical Evaluation: Run a Monte-Carlo analysis (e.g., 500 iterations) by adding artificial noise to the MS data to generate a flux distribution. Calculate 95% confidence intervals for each flux. Perform a χ2-test to assess goodness-of-fit.

5. Visualizations: Workflow and Pathways

G Tracer [1-13C]Glucose Tracer Culture Steady-State Cultivation (M. thermophila) Tracer->Culture Harvest Cell Harvest & Quenching Culture->Harvest MS_Prep Hydrolysis & Derivatization (GC-MS Sample) Harvest->MS_Prep GCMS GC-MS Measurement MS_Prep->GCMS MDV_Data Isotopologue Distribution Data (MDVs) GCMS->MDV_Data Comp Computational Flux Fitting MDV_Data->Comp Experimental Input Network Metabolic Network Model Network->Comp Stoichiometry Flux_Map Quantitative Flux Map Comp->Flux_Map

Diagram 1: 13C-MFA Experimental and Computational Workflow (88 chars)

G Glc Glucose [1-13C] G6P G6P Glc->G6P Uptake PYR Pyruvate G6P->PYR Glycolysis AcCoA Acetyl-CoA PYR->AcCoA PDH OAA Oxaloacetate (OAA) PYR->OAA Anaplerosis (PEPC/PyC) CIT Citrate AcCoA->CIT TCA Cycle MAL Malate (Target) OAA->MAL MDH OAA->CIT CS (With AcCoA) Export Secreted Malic Acid MAL->Export Transport

Diagram 2: Key Pathways for Malate Production in M. thermophila (87 chars)

6. The Scientist's Toolkit: Essential Reagent Solutions

Table 2: Key Research Reagents and Materials for 13C-MFA in *M. thermophila.*

Item / Reagent Solution Function / Application in Protocol
[1-13C]Glucose (99% atom purity) The primary tracer substrate. Enables tracking of carbon fate through metabolic networks.
Defined Minimal Medium (Thermophile-formulated) Ensures metabolic steady-state and eliminates background carbon sources that complicate MFA.
MTBSTFA Derivatization Reagent Silanizing agent for GC-MS sample prep. Produces volatile tert-butyldimethylsilyl (TBDMS) derivatives of amino acids.
DB-5MS GC Capillary Column Standard non-polar column for separation of TBDMS-amino acid derivatives prior to MS detection.
13C-FLUX / OpenFLUX Software Industry-standard computational platform for metabolic network modeling and flux estimation.
Nylon Membrane Filters (0.45μm) For rapid vacuum harvesting of fungal cells with minimal metabolite turnover.
Liquid Nitrogen For instantaneous quenching of metabolism after sampling.
6 M Hydrochloric Acid (HCl, TraceMetal Grade) For complete hydrolysis of cellular protein into constituent amino acids.

1. Introduction and Thesis Context Within a broader thesis investigating metabolic engineering strategies for malic acid overproduction in the thermophilic fungus Myceliophthora thermophila, 13C-Metabolic Flux Analysis (13C-MFA) is an indispensable tool. The core thesis posits that the unique physiology of thermophiles, compared to conventional mesophilic workhorses like Aspergillus oryzae or Saccharomyces cerevisiae, can be leveraged for more robust and efficient bioprocesses. This application note details the specific protocols and comparative advantages of applying 13C-MFA in thermophilic versus mesophilic systems, with a focus on malic acid pathway elucidation.

2. Comparative Quantitative Data Summary

Table 1: Key Physiological Parameters Impacting 13C-MFA Design in Thermophiles vs. Mesophiles

Parameter Thermophilic System (e.g., M. thermophila) Mesophilic System (e.g., A. oryzae) Implication for 13C-MFA
Optimal Growth Temp. 45-55°C 25-37°C Requires specialized, evaporation-minimized bioreactor setup for labeling.
Cultivation Doubling Time Often shorter (e.g., ~2-3h) Typically longer (e.g., ~4-6h) Faster metabolic steady-state achievement, but quicker labeling dynamics requiring precise sampling.
Membrane Fluidity High saturation of lipids More unsaturated lipids Affects substrate uptake kinetics, influencing tracer experiment design.
Enzyme Thermostability High Moderate In vitro enzyme assays for validation can be performed at elevated temps, reducing contaminant activity.
Contamination Risk Significantly Lower Higher Enables longer, more stable continuous cultivation runs for precise flux determination.

Table 2: Exemplary 13C-MFA Flux Results for Central Carbon Metabolism (Relative Flux, %)*

Metabolic Reaction M. thermophila (Malic Acid-Producing Strain) A. oryzae (Wild Type) Interpretation
Glucose → Pyruvate (Glycolysis) 85 ± 3 100 ± 4 Reduced glycolytic flux in engineered M. thermophila, channeling carbon elsewhere.
Pyruvate → Oxaloacetate (Anaplerotic) 45 ± 5 22 ± 3 Key Finding: Dramatically elevated anaplerotic flux in thermophile, crucial for malic acid precursor supply.
Oxaloacetate → Malate (MDH) 120 ± 8 35 ± 4 Key Finding: High reflux in TCA cycle and malate synthesis node in the engineered thermophile.
Pentose Phosphate Pathway (Oxidative) 15 ± 2 28 ± 3 Lower NADPH generation via PPP in M. thermophila, suggesting alternate redox balance mechanisms.

*Data are illustrative examples based on simulated and published 13C-MFA studies in fungal systems. Values normalized to glucose uptake rate = 100%.

3. Detailed Experimental Protocols

Protocol 3.1: Cultivation and 13C-Tracer Experiment for Thermophilic Fungi Objective: To achieve metabolic and isotopic steady-state in M. thermophila for subsequent 13C-MFA.

  • Pre-culture: Grow M. thermophila in defined minimal medium (e.g., Vogel's) with 20 g/L glucose at 50°C, 250 rpm for 24h.
  • Bioreactor Inoculation: Transfer pre-culture to a controlled bioreactor (1 L working volume) with identical medium. Maintain at 50°C, pH 6.0, DO >30%.
  • Tracer Pulse: At mid-exponential phase (OD600 ~10), rapidly switch the feed to an identical medium where 100% of the glucose is replaced with [1-13C]glucose (or other desired tracer).
  • Steady-State Verification: Monitor OD600 and off-gas CO2 (using MS for 13CO2) for at least 3 residence times post-switch. Isotopic steady-state is confirmed when 13CO2 fraction stabilizes (<2% change over 1h).
  • Biomass Quenching: Rapidly sample culture (10-15 mL) into –40°C 60% (v/v) aqueous methanol bath (<30 sec), centrifuge, wash, and store pellet at –80°C.

Protocol 3.2: GC-MS Analysis of Proteinogenic Amino Acids for Flux Determination Objective: To derive mass isotopomer distributions (MIDs) of proteinogenic amino acids from cellular biomass.

  • Hydrolysis: Hydrolyze 5-10 mg of dried biomass pellet with 6M HCl at 105°C for 24h under N2 atmosphere.
  • Derivatization:
    • Dry hydrolysate under N2 stream.
    • Add 50 µL acetonitrile and 50 µLCaboxylic acid) at 85°C for 1h.
    • Add 100 µL MSTFA (N-Methyl-N-(trimethylsilyl)trifluoroacetamide) at 85°C for 30 min.
  • GC-MS Analysis: Inject 1 µL sample. Use a DB-5MS column. Method: 100°C hold 2min, ramp 10°C/min to 320°C, hold 5min. Operate in electron impact (EI) mode, scan m/z 200-550.
  • MID Extraction: Integrate relevant fragment ions (e.g., alanine: m/z 260 [M-57]+, serine: m/z 390 [M-57]+). Correct for natural isotope abundances using standard algorithms (e.g., IsoCor).

Protocol 3.3: In Vitro Enzyme Activity Assay for Pathway Validation (Malate Dehydrogenase) Objective: Confirm flux predictions by measuring key enzyme activities.

  • Cell Extract Preparation: Suspend biomass in 50 mM Tris-HCl, pH 8.0, 2 mM MgCl2. Disrupt via bead-beating (4°C). Centrifuge at 15,000 x g for 20 min; use supernatant.
  • Assay Mix: For M. thermophila assay at 50°C: 50 mM HEPES (pH 7.5), 0.2 mM NADH, 0.5 mM Oxaloacetate, 2 mM MgCl2, appropriate cell extract.
  • Kinetics: Initiate reaction with oxaloacetate. Monitor NADH oxidation at 340 nm (ε340 = 6.22 mM-1 cm-1) for 3 min using a thermostatted spectrophotometer.
  • Calculation: Activity (U/mg protein) = (ΔA340/min) / (6.22 * mg protein in assay).

4. Visualizations

ThermophileMFA 13C-MFA Workflow for Thermophilic vs. Mesophilic Systems Start Define Objective: Malic Acid Pathway Fluxes SysSelect System Selection Start->SysSelect Tracer Design 13C-Tracer Experiment SysSelect->Tracer Thermophile (45-55°C) SysSelect->Tracer Mesophile (25-37°C) Cult Controlled Cultivation & Labeling Tracer->Cult Sample Rapid Sampling & Quenching Cult->Sample Prep Biomass Hydrolysis & Derivatization Sample->Prep Analyze GC-MS Analysis & MID Extraction Prep->Analyze Model Network Model Compilation Analyze->Model FluxFit Flux Fitting & Statistical Validation Model->FluxFit Output Comparative Flux Map & Interpretation FluxFit->Output

Title: 13C-MFA Comparative Workflow Diagram

MalicPathway Key Flux Differences in Malic Acid Synthesis Pathway Glc Glucose Pyr Pyruvate Glc->Pyr Glycolysis Flux OAA Oxaloacetate (OAA) Pyr->OAA Pyruvate Carboxylase FLUX: HIGH AcCoA Acetyl-CoA Pyr->AcCoA Pyruvate Dehydrogenase Mal Malate OAA->Mal Malate Dehydrogenase FLUX: VERY HIGH ICT Isocitrate OAA->ICT TCA Cycle FLUX: MODERATE MalicAcid Malic Acid (Product) Mal->MalicAcid Export/Conversion

Title: Malic Acid Synthesis Flux Differences

5. The Scientist's Toolkit: Research Reagent Solutions

Table 3: Essential Reagents and Materials for 13C-MFA in Thermophilic Systems

Item Function/Benefit Example/Specification
[1-13C]Glucose Primary tracer for elucidating glycolytic, PPP, and anaplerotic fluxes. Purity >99% atom 13C. Cambridge Isotope Laboratories (CLM-1396)
Thermostable Defined Medium Supports high-temperature growth without precipitation or degradation of components. Custom Vogel's or Czapek-Dox, with trace elements.
Evaporation Condenser Critical for bioreactor off-gas line. Prevents loss of culture volume and maintains osmolarity during 50-55°C cultivation. Cold finger or reflux condenser installed in bioreactor headplate.
N-Methyl-N-(trimethylsilyl)trifluoroacetamide (MSTFA) Derivatizing agent for GC-MS analysis of amino acids and metabolites. Essential for volatility. Sigma-Aldrich (69479)
High-Temperature GC-MS Inlet Liner Prevents degradation of derivatives and ensures sharp peaks. Deactivated, wool-packed for high boiling point compounds. Agilent (5190-2295)
13C-MFA Software Suite For flux calculation and statistical analysis from MID data. INCA (Isotopomer Network Compartmental Analysis), OpenFLUX
NADH (Disodium Salt) Cofactor for in vitro enzyme activity assays (e.g., MDH). High purity for accurate spectrophotometry. Roche (10128023001)

Current Knowledge Gaps and Research Questions in M. thermophila Malate Metabolism

1.0 Introduction and Context This document outlines critical application notes and experimental protocols designed to address knowledge gaps in the malate metabolism of Myceliophthora thermophila, within the broader thesis framework employing 13C-Metabolic Flux Analysis (13C-MFA) for optimizing malic acid production. The integration of 13C-MFA is pivotal for quantifying in vivo metabolic fluxes, thereby validating hypotheses and guiding metabolic engineering strategies.

2.0 Identified Knowledge Gaps and Corresponding Research Questions The following table synthesizes current knowledge gaps into actionable research questions.

Table 1: Key Knowledge Gaps and Research Questions in M. thermophila Malate Metabolism

Knowledge Gap Category Specific Research Question Relevance to 13C-MFA & Malate Production
Pathway Redundancy & Regulation What is the relative in vivo flux contribution of the reductive TCA (rTCA) via mitochondrial versus cytosolic malate dehydrogenase (MDH) isoforms under varying carbon sources (e.g., glucose vs. xylose)? 13C-MFA can partition flux between parallel pathways. Essential for determining the optimal engineering target (cytosolic vs. mitochondrial malate production).
Anaplerotic Node Control How is the phosphoenolpyruvate (PEP) carboxykinase (PCK) versus pyruvate carboxylase (PYC) node regulated under high malate yield conditions? Does PCK serve a net anaplerotic or gluconeogenic role? Critical for understanding PEP/pyruvate partitioning. 13C-MFA with [1-13C] glucose can resolve the relative activity of these enzymes.
Mitochondrial Transport What are the kinetics and capacity of the malate-citrate/pyruvate-citrate antiport systems? Is mitochondrial malate export a rate-limiting step during high-titer production? Defines a potential transport bottleneck. 13C-MFA coupled with intracellular metabolite profiling can infer transport constraints.
Redox Coupling How is NADH/NADPH cofactor balance maintained between glycolytic NADH production, mitochondrial respiration, and the NADPH-demanding rTCA pathway? Impacts metabolic flux distribution. 13C-MFA with labeling from [1,2-13C] glucose can trace NADPH production pathways.
Glyoxylate Shunt Activity Is the glyoxylate shunt active during growth on sugars, and does it provide a bypass for decarboxylation steps, potentially enhancing C4 acid yield? A functional shunt would significantly alter flux predictions. 13C-MFA patterns are distinct for glyoxylate cycle activity.

3.0 Detailed Experimental Protocols

3.1 Protocol: 13C-Tracer Experiment for Resolving rTCA Pathway Contributions

Objective: To quantify the relative flux through cytosolic vs. mitochondrial reductive TCA pathways for malate synthesis. Application Note: This protocol is foundational for addressing Gap 1 in Table 1.

Reagents & Culture Conditions:

  • M. thermophila strain (wild-type or engineered).
  • Defined mineral medium with 10 g/L [1-13C] Glucose (99% atom purity) as sole carbon source.
  • Controlled bioreactor set at 45°C, pH 5.5, aerobic conditions (DO > 30%).

Procedure:

  • Inoculum & Cultivation: Grow a pre-culture in unlabeled glucose medium. Harvest cells in mid-exponential phase, wash twice with saline, and inoculate into the 13C-labeled medium in a bioreactor to an initial OD600 of 0.5.
  • Sampling for 13C-MFA: Take rapid samples (5-10 mL) at steady-state growth (confirmed by constant CO2 evolution rate). a. Quenching: Immediately inject sample into 60% (v/v) aqueous methanol at -40°C. b. Metabolite Extraction: Use a cold methanol/chloroform/water extraction protocol. c. Derivatization: Derivatize proteinogenic amino acids (from hydrolyzed biomass) and intracellular metabolites (e.g., malate, succinate) to their tert-butyldimethylsilyl (TBDMS) derivatives for GC-MS analysis.
  • GC-MS Analysis & Flux Estimation: a. Analyze derivatized samples via GC-MS. b. Measure Mass Isotopomer Distributions (MIDs) of key fragment ions from amino acids (e.g., alanine, aspartate, glutamate) and central metabolites. c. Input MIDs, extracellular uptake/secretion rates, and growth data into a metabolic network model of M. thermophila (e.g., using INCA, OpenFLUX, or 13CFLUX2 software). d. Perform least-squares regression to estimate the flux map that best fits the experimental MIDs.

3.2 Protocol: CRISPR-Cas9 Mediated Gene Knockout to Validate PCK Function

Objective: To create a Δpck mutant and assess its impact on malate flux and yield, addressing Gap 2. Application Note: Functional genetics are required to assign directionality to fluxes inferred by 13C-MFA.

Reagents:

  • M. thermophila spheroplasts.
  • CRISPR-Cas9 plasmid containing gRNA targeting the pck gene and a selectable marker (e.g., hygromycin resistance).
  • PEG solution (40% w/v).
  • Regeneration agar plates with hygromycin.

Procedure:

  • gRNA Design & Plasmid Construction: Design a 20-nt guide RNA sequence targeting an early exon of the pck gene. Clone into a M. thermophila-optimized CRISPR-Cas9 expression plasmid.
  • Transformation: Prepare spheroplasts from wild-type mycelia using lytic enzymes. Mix 10^7 spheroplasts with 5-10 μg of purified plasmid DNA, then add 40% PEG solution. Incubate on ice, then at room temperature.
  • Regeneration & Selection: Plate the transformation mixture onto regeneration agar. After 24 hours, overlay with agar containing hygromycin. Incubate at 45°C for 5-7 days until transformants appear.
  • Genotype Validation: Isolate genomic DNA from putative knockouts. Confirm pck gene disruption by diagnostic PCR and Sanger sequencing across the target site.
  • Phenotype Analysis: Subject the validated Δpck mutant to the 13C-tracer experiment (Protocol 3.1). Compare the estimated fluxes (particularly at the PEP/pyruvate node) and malate yields to the wild-type strain.

4.0 Visualization of Key Metabolic Pathways and Workflows

G Glucose Glucose PEP PEP Glucose->PEP Glycolysis Pyr Pyr PEP->Pyr PK OAA_cyt OAA (cytosol) PEP->OAA_cyt PCK (?) Mal_mito Malate (mito) Pyr->Mal_mito ME? OAA_mito OAA (mito) Pyr->OAA_mito PYC Mal_cyt Malate (cytosol) OAA_cyt->Mal_cyt cMDH Secreted_Mal Secreted Malic Acid Mal_cyt->Secreted_Mal Mal_mito->Mal_cyt ? Malate Carrier OAA_mito->Mal_mito mMDH

Title: Key Nodes and Gaps in M. thermophila Malate Synthesis

G Start 1. Cultivate M. thermophila in [1-13C] Glucose Sample 2. Quench & Extract Metabolites Start->Sample MS 3. Derivatize & Analyze via GC-MS Sample->MS MID 4. Measure Mass Isotopomer Distributions (MIDs) MS->MID Model 5. Define Metabolic Network Model MID->Model Fit 6. Fit Estimated Fluxes to Experimental MIDs Model->Fit Fit->MID Iterative Regression Output 7. Output: Quantitative in vivo Flux Map Fit->Output

Title: 13C-MFA Workflow for Flux Quantification

5.0 The Scientist's Toolkit: Essential Research Reagent Solutions

Table 2: Key Reagents for 13C-MFA and Genetic Studies in M. thermophila

Reagent/Material Function/Application Key Consideration
[1-13C] Glucose (99% atom purity) Tracer substrate for 13C-MFA. Enables resolution of parallel pathways (e.g., PCK vs. PYC). Cost is significant; quantity required scales with bioreactor volume. Purity is critical for accurate MID measurement.
13C-Metabolic Flux Analysis Software (e.g., INCA) Software platform for stoichiometric modeling, isotopomer simulation, and non-linear parameter fitting to estimate fluxes. Requires a curated genome-scale metabolic model for M. thermophila. Steep learning curve but essential for quantitative analysis.
M. thermophila CRISPR-Cas9 Kit System for targeted gene knockout (e.g., pck) to validate hypotheses generated from 13C-MFA data. Requires optimization of spheroplast transformation and gRNA design for high efficiency.
Lyophilized Internal Standard Mix (13C, 15N labeled) Added during metabolite extraction for absolute quantification via GC-MS or LC-MS. Corrects for losses during sample processing. Must not interfere with natural abundance or tracer MIDs of target analytes.
Derivatization Reagents (e.g., MSTFA for TBDMS) Chemically modifies polar metabolites (organic acids, amino acids) for volatile, thermally stable derivatives suitable for GC-MS analysis. Must be performed under anhydrous conditions. Reaction time and temperature are critical for reproducibility.

A Step-by-Step Protocol: Designing and Executing 13C-MFA Experiments for M. thermophila

Selecting Optimal 13C-Labeled Tracers (e.g., [1-13C]Glucose, [U-13C]Glucose) for Malic Acid Pathway Elucidation

This application note, framed within a broader thesis on 13C-Metabolic Flux Analysis (13C-MFA) for malic acid production in Myceliophthora thermophila, provides a guide for selecting appropriate ¹³C-labeled glucose tracers. The primary aim is to elucidate the pathways of malic acid biosynthesis, distinguishing between cytosolic and mitochondrial contributions, and quantifying fluxes through key nodes like pyruvate carboxylase versus the glyoxylate shunt. The choice of tracer profoundly impacts the precision and resolvability of these fluxes.

Tracer Selection Rationale and Comparative Data

The optimal tracer choice depends on the specific metabolic question. The table below compares key tracers based on recent studies in filamentous fungi and related systems.

Table 1: Comparison of ¹³C-Labeled Glucose Tracers for Malic Acid Pathway Analysis

Tracer Key Diagnostic Power Advantage for Malic Acid Pathways Limitation Best Suited For
[1-¹³C]Glucose Labels C1 of 3PG/PEP/pyruvate. Yields labeling in C1 (via PC) or C4 (via PEPCK) of OAA/malate. Clearly distinguishes Pyruvate Carboxylase (PC) (malate C1 labeled) from PEP Carboxykinase (PEPCK) (malate C4 labeled) activity. Excellent for resolving glyoxylate shunt vs. PC. Does not provide information on TCA cycle symmetry or pentose phosphate pathway (PPP) activity. Labeling patterns can be complex if multiple pathways are active. Elucidating the primary anaplerotic route (PC vs. PEPCK) into OAA for malate synthesis.
[U-¹³C]Glucose Uniformly labels all carbon positions. Generates multiple labeling patterns (mass isotopomers) in metabolites. Provides comprehensive dataset for global MFA. Can resolve parallel pathways (e.g., glycolysis + PPP, complete vs. incomplete TCA). Detects reversibility in reactions. Expensive. Complex data interpretation and computational fitting. Potential for over-parameterization if model is not well-defined. Comprehensive, system-wide flux map quantification when the metabolic network is well-understood.
[1,2-¹³C₂]Glucose Generates unique C-C bond fragments. Preserves the C1-C2 bond from glucose through glycolysis. Powerful for analyzing TCA cycle kinetics, gluconeogenesis, and the glyoxylate shunt. Can distinguish mitochondrial vs. cytosolic acetyl-CoA pools. More complex data analysis than single-position labels. Less commonly used, so reference data may be limited. Probing metabolic compartmentalization and the fate of acetyl-CoA in relation to malate via the glyoxylate shunt.

Experimental Protocols

Protocol 1: Tracer Cultivation ofM. thermophilafor Malic Acid Production

Objective: To incorporate ¹³C-label from defined glucose tracers into the metabolome of M. thermophila under malic acid-producing conditions.

  • Pre-culture: Inoculate M. thermophila spores into a complex seed medium (e.g., containing 20 g/L unlabeled glucose). Incubate at 45°C, 200 rpm for 24h.
  • Cell Wash: Harvest cells by centrifugation (4000 x g, 10 min). Wash twice with sterile, carbon-free minimal salt medium (e.g., containing (NH₄)₂SO₄, KH₂PO₄, MgSO₄, CaCl₂, trace elements).
  • Tracer Cultivation: Resuspend the washed biomass in fresh minimal medium to an OD₆₀₀ of ~1.0. Add the selected ¹³C-labeled glucose tracer as the sole carbon source at a concentration of 20-40 g/L. Use mixtures (e.g., 20% [U-¹³C]Glucose + 80% unlabeled glucose) for cost-effective parallel labeling experiments (PLE).
  • Cultivation Conditions: Incubate at 45°C, 200 rpm. Maintain pH at 6.0-7.0 using automatic titration with 5M NaOH (which also titrates produced malic acid).
  • Sampling: At mid-exponential growth phase (determined from growth curves), rapidly sample culture broth (10-20 mL). Immediately quench metabolism by injecting into 40 mL of -40°C methanol:water (60:40, v/v) solution.
Protocol 2: Sample Processing and GC-MS Analysis of Proteinogenic Amino Acids and Malic Acid

Objective: To derive ¹³C labeling patterns in key metabolites for 13C-MFA.

  • Metabolite Extraction: Keep quenched samples at -20°C for 1h. Centrifuge (4000 x g, 10 min, -4°C). Collect supernatant for extracellular malic acid analysis. Wash the pellet with cold methanol, then hydrolyze the cellular protein to analyze proteinogenic amino acids as stable proxies for intracellular metabolite labeling.
  • Protein Hydrolysis: Dry the cell pellet. Add 6M HCl and hydrolyze at 105°C for 24h under vacuum. Dry the hydrolysate to remove HCl.
  • Derivatization (for GC-MS):
    • Amino Acids: Derivatize with N-(tert-Butyldimethylsilyl)-N-methyltrifluoroacetamide (MTBSTFA) at 85°C for 1h.
    • Malic Acid (from supernatant): Lyophilize the supernatant. Derivatize to the di-TMS ester using pyridine and N,O-Bis(trimethylsilyl)trifluoroacetamide (BSTFA) at 85°C for 1h.
  • GC-MS Analysis:
    • Use a DB-5MS or similar column.
    • Run method: Injector at 250°C, initial oven temp 100°C, ramp to 320°C.
    • Operate MS in electron impact (EI) mode at 70 eV. Use selected ion monitoring (SIM) to detect specific mass fragments (e.g., for malic acid, fragment m/z 233, 245, 335; for alanine, m/z 260, 261, 262).
  • Data Processing: Correct MS spectra for natural isotope abundances using software like IsoCor or MeltDB. Calculate Mass Isotopomer Distributions (MIDs) for each key fragment.

The Scientist's Toolkit: Research Reagent Solutions

Table 2: Essential Materials for 13C-Tracer Experiments in M. thermophila

Item Function/Benefit
[1-¹³C]Glucose (99% ¹³C) Tracer to specifically probe anaplerotic pathways (PC vs. PEPCK) into the OAA pool.
[U-¹³C]Glucose (99% ¹³C) Tracer for comprehensive, system-wide 13C-MFA to map complete network fluxes.
Carbon-Free Minimal Salt Medium Ensures the ¹³C-tracer is the sole carbon source, preventing dilution of the label.
MTBSTFA Derivatization Reagent Forms tert-butyldimethylsilyl (TBDMS) derivatives of amino acids for stable, volatile GC-MS analysis with informative fragmentation.
BSTFA + 1% TMCS Forms trimethylsilyl (TMS) derivatives of organic acids (like malate) for GC-MS analysis.
Authentic ¹³C-Labeled Standards e.g., [U-¹³C]Alanine, for validation of GC-MS retention times and fragmentation patterns.
Metabolic Flux Analysis Software (e.g., INCA, 13CFLUX2, OpenFLUX) Essential computational platform for integrating labeling data and growth phenotypes to calculate metabolic flux maps.

Visualizations

G Glucose Glucose G6P G6P Glucose->G6P Hexokinase PEP PEP G6P->PEP Glycolysis Pyr Pyr PEP->Pyr Pyruvate Kinase OAA_cyt OAA (cytosol) PEP->OAA_cyt PEPCK OAA_mito OAA (mito) Pyr->OAA_mito PC AcCoA_mito AcCoA_mito Pyr->AcCoA_mito PDH Mal_cyt Malate (cytosol) OAA_cyt->Mal_cyt MDH Mal_mito Malate (mito) OAA_mito->Mal_mito MDH Mal_mito->OAA_mito Icit Isocitrate AcCoA_mito->Icit TCA Cycle (Citrate Synthase, Aconitase) Suc Succinate Icit->Suc TCA Cycle Glyox Glyoxylate Icit->Glyox ICL Glyox->Mal_mito MS Uses AcCoA PC Pyruvate Carboxylase PEPCK PEPCK MDH MDH CS Citrate Synthase ICL Isocitrate Lyase MS Malate Synthase

Tracer Pathways for Malate Biosynthesis

workflow cluster_0 Experimental Phase cluster_1 Analytical & Computational Phase Step1 1. Culture & Labeling (Defined 13C-Tracer) Step2 2. Metabolic Quenching (-40°C Methanol/Water) Step1->Step2 Step3 3. Biomass Harvest (Centrifugation) Step2->Step3 Step4 4. Metabolite Extraction & Protein Hydrolysis Step3->Step4 Step5 5. Derivatization (MTBSTFA for AAs, BSTFA for Acids) Step4->Step5 Step6 6. GC-MS Analysis (MID Measurement) Step5->Step6 Step7 7. Isotopic Data Correction (e.g., IsoCor) Step6->Step7 Step8 8. 13C-MFA Flux Calculation (e.g., INCA) Step7->Step8 Step9 9. Flux Map & Statistical Validation Step8->Step9

13C-MFA Experimental Workflow

This application note details cultivation protocols for stable isotopic labeling experiments, specifically for ¹³C Metabolic Flux Analysis (¹³C-MFA), within the context of a research thesis focused on optimizing malic acid production in the thermophilic fungus Myceliophthora thermophila. The choice between chemostat (steady-state) and batch (dynamic) cultivation is critical for generating high-quality labeling data required for precise flux quantification. These strategies underpin relabeling experiments where a shift from natural abundance [¹²C]glucose to a defined mixture of [¹³C]glucose tracers is performed.

Core Cultivation Strategy Comparison

Table 1: Decision Matrix for Cultivation Mode in ¹³C-MFA Relabeling Experiments

Feature Chemostat Cultivation Batch Cultivation
Physiological State Steady-state (balanced growth) Dynamic (changing metabolites, growth phases)
Metabolic Fluxes Constant, well-defined Time-varying, complex
Labeling Transition Single step-change after steady-state is reached Initiated at inoculation or mid-growth phase
Data Interpretation Simplified; fluxes directly related to steady-state conditions Requires dynamic modeling; more complex
Key Requirement Must achieve steady-state (≥5 volume turnovers) prior to labeling Must define precise labeling timepoint (e.g., mid-exponential phase)
Throughput Lower, one condition per reactor Higher, multiple parallel bioreactors or flasks
Primary Application Precise, absolute flux quantification at a specific growth condition. Screening multiple strains/conditions; studying flux dynamics.
Suitability for M. thermophila Malic Acid Research Ideal for mapping fluxes under optimized, continuous production conditions. Ideal for profiling flux changes during acid production phase in batch.

Detailed Experimental Protocols

Protocol 3.1: Chemostat Cultivation for Steady-State ¹³C Relabeling

Objective: To achieve a metabolic and isotopic steady-state for accurate ¹³C-MFA of M. thermophila.

Materials: Bioreactor with pH, temperature, and dissolved oxygen (DO) control; peristaltic pumps for feed and harvest; sterile medium reservoir; effluent collection vessel.

Procedure:

  • Inoculum Preparation: Grow M. thermophila in a seed culture (e.g., 100 mL) on natural glucose medium until late-exponential phase.
  • Bioreactor Setup & Batch Phase: Transfer inoculum to bioreactor containing defined production medium with natural glucose. Allow batch growth until late-exponential phase (OD₆₀₀ ~10-15), while controlling temperature at 45°C and pH at 5.5 (optimal for malic acid production).
  • Initiation of Continuous Operation: Start feeding fresh medium (with natural glucose) at the predetermined dilution rate (D, e.g., 0.05 h⁻¹). Simultaneously start harvesting effluent at the same flow rate. Record this time as t=0 for continuous culture.
  • Steady-State Attainment: Monitor OD₆₀₀, residual glucose, and malic acid titers in the effluent. Steady-state is achieved when these parameters vary by <2% over at least 5 residence times (τ = 1/D). For D=0.05 h⁻¹, this requires >100 hours of continuous operation.
  • ¹³C Tracer Pulse: At steady-state, swiftly switch the feed medium reservoir from natural glucose to an isotopically defined tracer mixture (e.g., [1-¹³C]glucose or a mixture). Ensure the medium composition (C,N,P sources) is otherwise identical.
  • Isotopic Steady-State Sampling: Allow the culture to undergo 4-5 volume turnovers after the switch to ensure complete replacement of intracellular metabolite pools with new isotopic labels. Sample biomass (for proteinogenic amino acids) and extracellular metabolites (malic acid, etc.) for GC-MS analysis.

Protocol 3.2: Batch Cultivation for Dynamic ¹³C Labeling

Objective: To investigate metabolic fluxes during the malic acid production phase in a batch system.

Materials: Shake flasks or parallel bioreactor system; defined production medium; tracer substrate.

Procedure:

  • Pre-culture: Grow inoculum as in Protocol 3.1.
  • Labeled Batch Initiation (Forward Labeling): Inoculate the main production medium, prepared entirely with the desired ¹³C tracer mixture, directly with the pre-culture. This labels metabolism from the start.
  • Pulse-Chase Labeling (Alternative): Inoculate with natural glucose medium. During the early production phase (e.g., when glucose begins to deplete and malic acid accumulation accelerates), rapidly add a concentrated pulse of ¹³C tracer (e.g., [U-¹³C]glucose). This "pulse" is followed by a "chase" with natural glucose to track label dynamics.
  • Time-Course Sampling: Take frequent samples (every 1-3 hours) post-inoculation or post-pulse. Immediately quench metabolism (e.g., in cold 60% methanol). Analyze for metabolite concentrations (HPLC) and labeling patterns (GC-MS) of intracellular intermediates (from quenched samples) and extracellular malic acid.

Visualizing Workflows and Logical Frameworks

ChemostatWorkflow Start Inoculum Prep (Natural Glucose) BatchPhase Bioreactor Batch Phase (Growth to Late-Exp) Start->BatchPhase StartCont Initiate Continuous Feed (D = 0.05 h⁻¹, Natural Glu) BatchPhase->StartCont AttainSS Monitor & Attain Steady-State (≥5τ) StartCont->AttainSS SwitchLabel Switch Feed to ¹³C Tracer Medium AttainSS->SwitchLabel IsotopicSS Achieve Isotopic Steady-State (4-5τ) SwitchLabel->IsotopicSS Sample Harvest Biomass & Extracellular Metabolites IsotopicSS->Sample Analyze GC-MS & HPLC Analysis for ¹³C-MFA Sample->Analyze

Diagram 1: Chemostat Relabeling Protocol Workflow (98 chars)

BatchLabelingLogic Goal Goal: Quantify Fluxes in Production Phase Choice Labeling Strategy? Goal->Choice Forward Forward Labeling (Start with ¹³C Tracer) Choice->Forward Simpler PulseChase Pulse-Chase (Pulse ¹³C during production) Choice->PulseChase Captures transients DynamicSamp Intensive Time-Course Sampling Forward->DynamicSamp PulseChase->DynamicSamp Model Apply Dynamic ¹³C-MFA Model DynamicSamp->Model Output Time-Resolved Flux Map Model->Output

Diagram 2: Batch Cultivation Strategy Decision Logic (99 chars)

The Scientist's Toolkit: Key Research Reagents & Materials

Table 2: Essential Toolkit for ¹³C Labeling Cultivation Experiments

Item Function & Specification Application Notes for M. thermophila
Defined Mineral Medium Provides essential C, N, P, S, and trace metals without unlabeled organic buffers. Use ammonium sulfate as N-source; pH adjusted with NaOH/HCl. Optimized for high malate yield.
¹³C-Labeled Glucose Tracers Substrate for relabeling. Common mixtures: [1-¹³C], [U-¹³C], or mixtures like 20% [U-¹³C] + 80% natural. Purity >99% atom ¹³C. Critical for designing informative labeling experiments.
In-Line Bioreactor Sensors pH, DO, temperature probes. Essential for maintaining reproducibility. M. thermophila requires 45-50°C and controlled low pH for acid production.
Metabolism Quenching Solution Cold 60% Methanol (in water, -40°C). Rapidly halts metabolic activity to preserve in vivo labeling patterns of intracellular metabolites.
Centrifugal Filter Units 3 kDa molecular weight cut-off. For rapid separation and concentration of extracellular metabolites (malic acid, succinate) from culture broth.
Derivatization Reagents MSTFA (N-Methyl-N-(trimethylsilyl)trifluoroacetamide) for GC-MS. Converts amino acids (from hydrolyzed biomass) and organic acids into volatile trimethylsilyl derivatives.
Internal Standards for GC-MS ¹³C-labeled amino acid mix (e.g., U-¹³C algal hydrolysate). Corrects for instrumental variation and quantifies absolute amounts in Mass Spectrometry.

Sample Quenching, Extraction, and Preparation for Metabolite Analysis

Within the broader thesis investigating the metabolic flux network governing malic acid overproduction in Myceliophthora thermophila via 13C-Metabolic Flux Analysis (13C-MFA), the accuracy of the entire study hinges on the instantaneous capture of the intracellular metabolic state. Sample quenching and extraction are critical first steps to prevent metabolite turnover and ensure quantitative data that faithfully represents the in vivo fluxes. This protocol details the optimized procedures for quenching metabolism, extracting intracellular metabolites, and preparing samples for subsequent LC-MS/MS analysis, specifically tailored for the thermophilic fungus M. thermophila.

Research Reagent Solutions Toolkit

Table 1: Essential Reagents and Materials for Metabolite Quenching & Extraction

Reagent/Material Function & Rationale
60% (v/v) Cold Methanol (-40°C) Quenching solution. Rapidly cools cells, inhibits enzyme activity, and is compatible with thermophilic organisms to prevent cold shock leakage.
0.9% (w/v) Ammonium Bicarbonate (4°C) Wash solution. Removes extracellular metabolites while maintaining osmotic pressure to minimize cell lysis during washing.
Methanol:Water (4:1, v/v, -20°C) Extraction solvent. Efficiently solubilizes a broad range of polar metabolites while inactivating enzymes.
Chloroform (-20°C) Used in biphasic extraction for comprehensive metabolite recovery, separating polar (aqueous) and non-polar (organic) phases.
Liquid Nitrogen For instantaneous freezing of cell pellets post-quenching, halting all biochemical activity until extraction.
Lyo/Bead Mill Homogenizer Essential for mechanical disruption of the robust cell wall of M. thermophila to ensure complete metabolite release.
Cryo-cooled Centrifuge Maintains samples at sub-zero temperatures during centrifugation steps to prevent metabolite degradation.
SpeedVac Concentrator Gently removes extraction solvents under reduced pressure to concentrate metabolites prior to analysis.
LC-MS/MS Grade Water & Methanol High-purity solvents for sample reconstitution to avoid background interference during sensitive LC-MS/MS analysis.

Detailed Experimental Protocols

Protocol 3.1: Rapid Quenching ofM. thermophilaMetabolism

Objective: To instantly halt metabolic activity in cultures without causing cell lysis.

  • Pre-chill: Ensure 60% methanol (-40°C) and 0.9% ammonium bicarbonate (4°C) are ready. Pre-cool centrifuge to -20°C.
  • Sampling: Rapidly transfer a known volume of M. thermophila culture (e.g., 20 mL from a fermenter) directly into a tube containing 40 mL of cold 60% methanol (-40°C). Vortex immediately for 10 seconds.
  • Centrifugation: Pellet cells at 5,000 x g for 5 minutes at -20°C.
  • Wash: Carefully decant supernatant. Resuspend pellet in 10 mL of ice-cold 0.9% ammonium bicarbonate. Centrifuge again at 5,000 x g for 5 min at 4°C.
  • Flash-Freeze: Decant wash, immediately flash-freeze cell pellet in liquid nitrogen. Store at -80°C until extraction.

Protocol 3.2: Intracellular Metabolite Extraction via Methanol/Water

Objective: To quantitatively extract polar intracellular metabolites.

  • Cooling: Pre-cool bead mill homogenizer chamber with liquid nitrogen or dry ice.
  • Homogenization: Transfer frozen cell pellet to the chamber with 2 mL of cold methanol:water (4:1, v/v, -20°C). Homogenize at high speed for 3 cycles of 60 seconds, keeping samples cold between cycles.
  • Incubation: Transfer the slurry to a new tube. Vortex for 30 minutes at 4°C.
  • Centrifugation: Centrifuge at 14,000 x g for 20 minutes at -10°C.
  • Collection: Collect the supernatant (containing metabolites) into a fresh tube. Keep on dry ice.
  • Second Extraction: Re-extract the pellet with 1 mL of cold extraction solvent, vortex, centrifuge, and pool supernatants.
  • Concentration: Dry the pooled supernatant in a SpeedVac concentrator (no heat).
  • Storage/Reconstitution: Store dried metabolite extract at -80°C. Reconstitute in appropriate LC-MS/MS mobile phase for analysis.

Protocol 3.3: Comprehensive Biphasic Extraction (for Lipids & Polar Metabolites)

Objective: To simultaneously extract a wide spectrum of polar and non-polar metabolites.

  • After homogenization (Step 2 of Protocol 3.2), add 2 mL of chloroform (-20°C) to the slurry.
  • Vortex vigorously for 30 minutes at 4°C.
  • Add 1.6 mL of LC-MS grade water, vortex for 2 minutes.
  • Centrifuge at 3,500 x g for 15 minutes at 4°C to achieve phase separation.
  • Collection: Carefully collect the upper aqueous phase (polar metabolites) and the lower organic phase (lipids) into separate tubes.
  • Dry both phases separately using a SpeedVac. Reconstitute as needed.

Data Presentation: Key Parameters & Considerations

Table 2: Quantitative Parameters for Quenching & Extraction of M. thermophila

Parameter Recommended Specification Rationale / Impact
Quenching Solution Temp. -40°C ± 2°C Cools cells below 0°C in <1 second, minimizing leakage. Warmer temps slow quenching.
Quenching Solution Ratio 2:1 (Quencher:Culture) Ensures rapid and uniform temperature drop. Lower ratios risk incomplete quenching.
Quenching to Freeze Time ≤ 3 minutes Critical window to prevent metabolite turnover before stable storage at -80°C.
Extraction Solvent Temp. ≤ -20°C Maintains enzyme inactivation during the extraction process.
Cell Disruption Bead-beating (3x 60s) Mandatory for robust fungal cell walls. Less vigorous methods yield lower metabolite levels.
Pellet-to-Solvent Ratio ~50 mg cells: 1 mL solvent Ensures complete metabolite elution and prevents solvent saturation.
Extract Storage Dried, under inert gas, -80°C Prevents oxidative degradation and hydrolysis of labile metabolites.

Visualized Workflows

quenching_workflow Start Active M. thermophila Culture (37°C) Q1 Rapid Mixing with Cold 60% Methanol (-40°C) Start->Q1 Instantaneous Q2 Centrifuge (-20°C) & Wash Q1->Q2 Q3 Flash Freeze Pellet in Liquid N₂ Q2->Q3 E1 Cryo-Homogenization in MeOH:H₂O (4:1, -20°C) Q3->E1 Stored at -80°C E2 Vortex & Centrifuge E1->E2 E3 Collect Supernatant (Polar Metabolites) E2->E3 P1 SpeedVac Dry E3->P1 P2 Reconstitute in LC-MS/MS Solvent P1->P2 End LC-MS/MS Analysis for 13C-MFA P2->End

Quenching to LC-MS/MS Sample Prep Workflow

mfa_context ThesisGoal Thesis Goal: 13C-MFA Model for Malic Acid Overproduction CriticalStep Accurate Measurement of Intracellular Metabolite Pools & 13C-Labeling ThesisGoal->CriticalStep ThisProtocol THIS PROTOCOL: Robust Quenching & Extraction CriticalStep->ThisProtocol Foundation Provides Foundational Data (Pool Sizes & Labeling) ThisProtocol->Foundation FluxCalc Flux Calculation & Model Validation Foundation->FluxCalc FluxCalc->ThesisGoal Feedback

Protocol Role in 13C-MFA Thesis Framework

This application note details protocols for Gas Chromatography-Mass Spectrometry (GC-MS) and Liquid Chromatography-Mass Spectrometry (LC-MS) used to measure ¹³C isotopomer patterns. These techniques are critical for ¹³C Metabolic Flux Analysis (¹³C-MFA) within a thesis investigating metabolic pathway optimization for malic acid overproduction in the thermophilic fungus Myceliophthora thermophila. Accurate isotopomer quantification is essential for inferring in vivo metabolic fluxes, enabling the rational engineering of this industrially relevant organism.

GC-MS Protocol for Derivatized Metabolic Intermediates

GC-MS is ideal for analyzing volatile derivatives of central carbon metabolites (e.g., organic acids, amino acids, sugars) from cell extracts.

Reagents & Materials

Table: Key Research Reagent Solutions for GC-MS Sample Preparation

Reagent/Material Function/Brief Explanation
Methoxyamine hydrochloride (20 mg/mL in pyridine) Protects carbonyl groups (aldehydes/ketones) via methoximation, preventing tautomerization.
N-Methyl-N-(trimethylsilyl)trifluoroacetamide (MSTFA) Silylation agent; replaces active hydrogens (-OH, -COOH, -NH) with trimethylsilyl groups, increasing volatility and thermal stability.
Retention Time Index (RTI) alkane mix (e.g., C8-C40) Allows for precise calculation of retention indices for metabolite identification across different runs.
¹³C-labeled internal standard (e.g., [U-¹³C] succinic acid) Corrects for variations in derivatization efficiency, injection volume, and instrument sensitivity.
Anhydrous pyridine Solvent for methoximation; must be anhydrous to prevent hydrolysis of derivatizing agents.

Detailed Protocol

  • Quenching & Extraction: Rapidly filter M. thermophila culture (5-10 mg dry cell weight). Quench cells in 60% aqueous methanol at -40°C. Extract intracellular metabolites using a 40:40:20 methanol:acetonitrile:water mixture at -20°C for 1 hour. Centrifuge, collect supernatant, and dry under a gentle nitrogen stream.
  • Derivatization: a. Add 50 µL of methoxyamine solution to the dried pellet. Vortex vigorously and incubate at 30°C for 90 minutes with shaking. b. Add 100 µL of MSTFA, vortex, and incubate at 37°C for 30 minutes.
  • GC-MS Analysis:
    • Column: Mid-polarity stationary phase (e.g., DB-35MS, 30 m x 0.25 mm ID, 0.25 µm film).
    • Inlet: 250°C, splitless mode.
    • Carrier Gas: Helium, constant flow (1.0 mL/min).
    • Oven Program: Start at 80°C (hold 2 min), ramp at 5°C/min to 330°C, hold 5 min.
    • Transfer Line: 280°C.
    • Ion Source: Electron Impact (EI) at 70 eV, 230°C.
    • Detection: Full scan mode (m/z 50-600) or Selected Ion Monitoring (SIM) for target fragments.

LC-MS/MS Protocol for Polar Metabolites and Co-factors

LC-MS is suited for labile, polar, or non-derivatizable metabolites (e.g., glycolytic intermediates, nucleotides, cofactors like NADH).

Reagents & Materials

Table: Key Research Reagent Solutions for LC-MS/MS Analysis

Reagent/Material Function/Brief Explanation
Ion-pairing reagent (e.g., Tributylamine, TBA) Enhances retention of highly polar, anionic metabolites (e.g., organic acids, phosphorylated sugars) on reversed-phase columns.
Stable isotope-labeled internal standards (e.g., ¹³C¹⁵N-cell extract) Complex standard matching the sample matrix for accurate quantification and correction of ionization suppression.
High-purity solvents (Optima LC-MS grade) Minimizes background ions and reduces instrument contamination, crucial for sensitive detection.
Ammonium bicarbonate (e.g., 10 mM, pH 9.0) Mobile phase additive for HILIC (Hydrophilic Interaction Liquid Chromatography) separation of polar metabolites.
Quenching solution (60% methanol, -40°C) Instantly halts metabolism without causing cell lysis or metabolite leakage.

Detailed Protocol

  • Quenching & Extraction: As in 1.2, but consider alternative quenching (cold saline for LC-MS). Extract with 80% ethanol buffered with HEPES or ammonium acetate (pH 7.4). Dry under vacuum.
  • Sample Reconstitution: Reconstitute dried extracts in 100 µL of appropriate starting mobile phase compatible with the LC method.
  • LC-MS/MS Analysis (Ion-Pairing Reversed-Phase Method):
    • Column: C18 column (e.g., 2.1 x 150 mm, 1.7 µm).
    • Mobile Phase A: 10 mM Tributylamine, 15 mM acetic acid in 97:3 water:methanol (pH ~5.0).
    • Mobile Phase B: Methanol.
    • Gradient: 0% B for 2 min, to 20% B at 5 min, to 55% B at 15 min, to 100% B at 18 min, hold 4 min, re-equilibrate.
    • Flow Rate: 0.2 mL/min. Column Temp: 35°C.
    • MS Detection: Electrospray Ionization (ESI) negative mode. Multiple Reaction Monitoring (MRM) transitions optimized for each target metabolite and its ¹³C-isotopologs.
  • LC-MS/MS Analysis (HILIC Method for Polar Metabolites):
    • Column: ZIC-pHILIC (5 µm, 150 x 4.6 mm).
    • Mobile Phase A: 20 mM ammonium carbonate, 0.1% ammonium hydroxide (pH 9.2) in water.
    • Mobile Phase B: Acetonitrile.
    • Gradient: 80% B to 20% B over 20 min, hold 5 min.
    • MS Detection: ESI positive/negative mode switching. High-resolution full scan (e.g., Orbitrap) for accurate mass and isotopologue distribution.

Data Processing and Isotopomer Analysis

Table: Comparison of GC-MS and LC-MS for ¹³C-MFA in M. thermophila

Parameter GC-MS (with derivatization) LC-MS/MS (direct injection)
Typical Metabolites Amino acids, organic acids (TCA cycle), sugars Phosphorylated sugars, organic acids, nucleotides, cofactors
Sample Prep Complex, requires chemical derivatization Simpler, often direct injection of extract
Fragmentation High-energy EI (reproducible, library-matchable) Low-energy CID (soft, parent ion specific)
Quantification Based on fragment ion intensities; requires correction for natural isotopes Based on precursor or product ion intensities; susceptible to matrix effects
Throughput High for derivatized compound sets High, adaptable to automation
Key for MFA Mass isotopomer distributions (MIDs) of key fragments MIDs of intact molecules or specific fragments

MID Calculation: For each metabolite ion/fragment, the fractional abundance of each mass isotopologue (M+0, M+1, M+2,... M+n) is calculated as: Abundance(M+i) / Σ(Abundance(M+0 to M+n)).

Visualization of Workflows and Pathways

GCMS_Workflow Start M. thermophila Culture Quenching Extract Metabolite Extraction (MeOH:ACN:H₂O) Start->Extract Dry Sample Drying (N₂ Stream) Extract->Dry MOX Methoximation (90 min, 30°C) Dry->MOX Silyl Silylation (MSTFA, 30 min, 37°C) MOX->Silyl Inj GC-MS Injection Silyl->Inj Data EI-MS Data Acquisition Inj->Data MID MID Calculation & Flux Analysis Data->MID

Title: GC-MS Metabolite Analysis Workflow for 13C-MFA

MFA_Core Labeling 13C Tracer Experiment (e.g., [1-13C] Glucose) Sampling Metabolite Sampling at Isotopic Steady State Labeling->Sampling MS_Analysis GC/LC-MS Analysis Sampling->MS_Analysis MID_Data Measured Mass Isotopomer Data MS_Analysis->MID_Data MFA_Model 13C-MFA Computational Model MID_Data->MFA_Model Network Stoichiometric Metabolic Network of M. thermophila Network->MFA_Model Fluxes Estimated In Vivo Metabolic Flux Map MFA_Model->Fluxes Validation Model Fit Validation & Hypothesis Testing MFA_Model->Validation Iterative Fitting

Title: Core 13C-MFA Process from Tracer to Fluxes

MalicAcidPathway cluster_TCA TCA Cycle & Anaplerosis cluster_Glyox Possible Glyoxylate Shunt Glc [1-13C] Glucose (Labeled Tracer) G6P Glucose-6-P (M+1) Glc->G6P glycolysis PYR Pyruvate (M+1 / M+2) G6P->PYR AcCoA Acetyl-CoA (M+1 / M+2) PYR->AcCoA PDH OAA Oxaloacetate (OAA) PYR->OAA pyruvate carboxylase (Key Anaplerotic Rx) AcCoA->OAA citrate synthase MAL Malate (MAL) (Target Product) OAA->MAL MDH CIT Citrate OAA->CIT citrate synthase CIT->MAL via TCA cycle ICA Isocitrate GLYX Glyoxylate ICA->GLYX GLYX->MAL malate synthase SUC Succinate

Title: Key Labeling Routes from 13C-Glucose to Malate in M. thermophila

Within the broader thesis "High-Yield Malic Acid Production in Myceliophthora thermophila via 13C-Metabolic Flux Analysis (13C-MFA)," precise quantification of intracellular metabolic fluxes is paramount. This protocol details the application of data integration software—specifically INCA (Isotopomer Network Compartmental Analysis) and OpenFLUX—for constructing genome-scale metabolic models and calculating absolute metabolic fluxes from 13C-labeling experiments. The objective is to identify flux bottlenecks and optimize the tricarboxylic acid (TCA) cycle and glyoxylate shunt for enhanced malate synthesis in this thermophilic fungus.

Key Software Comparison and Quantitative Data

Table 1: Comparative Analysis of 13C-MFA Software for M. thermophila Studies

Feature INCA (v2.2+) OpenFLUX (v2.0+) Suitability for Malic Acid Pathway Analysis
Core Algorithm Elementary Metabolic Units (EMU) EMU / Non-Stationary MFA Both suitable for steady-state TCA cycle analysis
User Interface MATLAB-based GUI Python-based, script-driven INCA preferred for iterative model debugging
Parallelization Limited High (supports HPC clusters) OpenFLUX advantageous for large-scale network variants
Isotopomer Data Input MS & NMR fragment data Primarily MS data INCA supports broader data integration
Flux Uncertainty Estimation Monte Carlo sampling Built-in sensitivity analysis Both provide essential statistical validation
Model Compartmentalization Explicit (cytosol, mitochondria) Explicit Critical for M. thermophila fungal metabolism
Licensing Cost ~$2000 (academic) Open Source OpenFLUX reduces thesis research overhead
Typical Flux Solution Time 5-15 min (200-reaction network) 2-8 min (with parallelization) Comparable for core central carbon model

Table 2: Exemplar Flux Results from M. thermophila 13C-Glucose Experiment

Metabolic Reaction (Net Flux) Flux Value (µmol/gDCW/h) 95% Confidence Interval Software Used for Estimation
Glucose Uptake 850.0 ± 22.5 INCA
Pyruvate Dehydrogenase (Mitochondrial) 410.2 ± 18.7 INCA
Citrate Synthase 280.5 ± 15.3 OpenFLUX
Malate Synthase (Glyoxylate Shunt) 125.6 ± 9.8 INCA
Mitochondrial Malate Dehydrogenase 395.4 ± 20.1 OpenFLUX
Malic Acid Export (Theoretical) 102.3 ± 12.4 INCA
Anaplerotic PEP Carboxylase 88.7 ± 7.5 OpenFLUX

Experimental Protocols

Protocol 3.1: Tracer Experiment forM. thermophilaMalate Production

Objective: Generate 13C-labeling data for flux calculation.

  • Culture & Labeling: Grow M. thermophila (e.g., strain C1) in defined mineral medium in a chemostat (D=0.05 h⁻¹, pH 6.0, 45°C). Feed with a mixture of 80% [1-13C]glucose and 20% [U-12C]glucose at 10 g/L total concentration.
  • Quenching & Extraction: Rapidly sample 10 mL culture into 40 mL cold (-40°C) 60% aqueous methanol. Centrifuge (5 min, -20°C, 5000×g). Extract intracellular metabolites using cold 75% ethanol with 0.1% formic acid.
  • Derivatization for GC-MS: Dry extract under N₂. Derivatize with 20 µL methoxyamine hydrochloride (20 mg/mL in pyridine; 90 min, 30°C) followed by 50 µL MSTFA (N-Methyl-N-(trimethylsilyl)trifluoroacetamide; 60 min, 37°C).
  • Mass Spectrometry: Analyze derivatized samples via GC-MS (e.g., Agilent 8890/5977B). Use a DB-5MS column (30 m × 0.25 mm × 0.25 µm). Program: 80°C for 2 min, ramp 10°C/min to 320°C, hold 5 min. Operate in electron impact (EI) mode, scan m/z 50-600.
  • Data Processing: Integrate mass isotopomer distributions (MIDs) for key fragments (e.g., Alanine [M-57]⁺ m/z 116-119, Aspartate [M-57]⁺ m/z 130-134). Correct for natural isotope abundance using IsoCor or similar software.

Protocol 3.2: Metabolic Network Construction for INCA/OpenFLUX

Objective: Build a stoichiometric model of M. thermophila central carbon metabolism.

  • Database Curation: Start with a genome-scale reconstruction (e.g., from ModelSEED or CarveMe). Extract core reactions: Glycolysis (EMP), Pentose Phosphate Pathway (PPP), TCA Cycle, Glyoxylate Shunt, Anaplerotic Reactions (PEP carboxylase, pyruvate carboxylase), Malic Acid Transport.
  • Compartmentalization: Define two compartments: cytosol (c) and mitochondria (m). Include transport reactions for metabolites like pyruvate, oxaloacetate, malate, and cofactors (NAD/NADH).
  • Atom Transition Mapping: For each reaction in the network, define the exact carbon atom transitions. Use databases (e.g., MetaCyc) and manual biochemical literature curation. This is critical for 13C-MFA. Example: For mitochondrial malate dehydrogenase (mMDH), map Oxaloacetate (C1-C4) + NADH → Malate (C1-C4) + NAD⁺.
  • Software Implementation (INCA):
    • Launch INCA, create new project.
    • Input reactions via GUI or script: reaction mMDH: oaa_m + nadh_m <=> mal_m + nad_m
    • Define atom transitions: oaa_m{C1->mal_mC1, C2->mal_mC2, C3->mal_mC3, C4->mal_mC4}
    • Set network constraints: Glucose uptake = 850 µmol/gDCW/h; Biomass composition from experimental data.
  • Software Implementation (OpenFLUX):
    • Prepare an Excel template with reaction list, stoichiometry, and atom mappings.
    • Use the OpenFLUX parser to generate the model file (model.m).
    • Define free and fixed fluxes in the MATLAB/Python script.

Protocol 3.3: Flux Estimation and Statistical Validation

Objective: Calculate the most probable flux map and assess confidence intervals.

  • Data Integration: Load the corrected MIDs from Protocol 3.1 into the software.
  • Flux Estimation (INCA):
    • Use the INCA_lsq function to perform least-squares regression, minimizing the difference between simulated and experimental MIDs.
    • Run the optimization 20 times from random starting points to find the global minimum.
  • Flux Estimation (OpenFLUX):
    • Execute the generated script (main_flux_estimation.m) which calls fmincon or a similar optimizer.
    • Employ parallel computing toolbox for multiple starts.
  • Statistical Analysis:
    • Perform Monte Carlo analysis (1000 iterations) by adding Gaussian noise to the experimental MIDs (based on measured standard deviation).
    • Calculate 95% confidence intervals for each flux from the resulting distribution.
    • Evaluate goodness-of-fit via chi-squared test.

Diagrams

Diagram 1: 13C-MFA Workflow for Malic Acid Production

Workflow Labeling [1-13C]Glucose Tracer Experiment Culture M. thermophila Chemostat Culture Labeling->Culture Extraction Metabolite Extraction & Derivatization Culture->Extraction GCMS GC-MS Analysis (MID Measurement) Extraction->GCMS DataCorr Natural Isotope Correction GCMS->DataCorr ModelBuild Network Construction (INCA/OpenFLUX) DataCorr->ModelBuild AtomMap Define Carbon Atom Transitions ModelBuild->AtomMap FluxFit Flux Estimation & Nonlinear Fitting AtomMap->FluxFit Stats Monte Carlo Uncertainty Analysis FluxFit->Stats Output Flux Map for Malic Acid Pathway Stats->Output

Diagram 2: Key Malic Acid Synthesis Pathways in M. thermophila

Pathways cluster_TCA TCA Cycle (Mitochondria) cluster_Glyox Glyoxylate Shunt cluster_Anaplerotic Anaplerotic & Export Glucose Glucose Pyr_c Pyruvate (c) Glucose->Pyr_c Glycolysis Pyr_m Pyruvate (m) Pyr_c->Pyr_m Transport OAA_c Oxaloacetate (c) Pyr_c->OAA_c PEPC AcCoA_m Acetyl-CoA (m) Pyr_m->AcCoA_m PDH OAA_m Oxaloacetate (m) AcCoA_m->OAA_m   Cit_m Citrate (m) AcCoA_m->Cit_m CS Mal_m Malate (m) OAA_m->Mal_m (reversible) ICit_m Isocitrate (m) Cit_m->ICit_m AKG_m α-Ketoglutarate (m) ICit_m->AKG_m ICL (Glyoxylate Shunt) ICit_m->AKG_m IDH Glyox Glyoxylate (m) ICit_m->Glyox ICL Suc_m Succinate (m) AKG_m->Suc_m Suc_m->Mal_m Mal_m->OAA_m mMDH Mal_c Malate (c) Mal_c->Mal_m Transport Malate_Export Malic Acid (Export) Mal_c->Malate_Export Glyox->Mal_m MS + AcCoA_m OAA_c->Mal_c cMDH

The Scientist's Toolkit

Table 3: Essential Research Reagent Solutions for 13C-MFA of M. thermophila

Item Function/Description Key Consideration for Protocol
[1-13C]Glucose (99% enrichment) Tracer substrate for generating measurable isotopomer patterns in TCA/glyoxylate intermediates. Use mixture with unlabeled glucose (e.g., 80:20) to avoid full labeling which reduces flux resolvability.
Defined Mineral Medium (e.g., Vogel's) Ensures precise control of nutrient availability, eliminating background carbon sources. Must be optimized for M. thermophila growth at 45°C; chemostat operation is ideal for metabolic steady-state.
Cold (-40°C) 60% Methanol Quenching Solution Rapidly halts metabolism to "snapshot" intracellular metabolite levels. Volume ratio of 4:1 (quencher:culture) is critical for immediate temperature drop and enzyme inactivation.
Methoxyamine Hydrochloride in Pyridine First derivatization step for GC-MS; protects carbonyl groups, forming methoximes. Prepare fresh daily to avoid moisture absorption and degradation; pyridine must be handled in fume hood.
N-Methyl-N-(trimethylsilyl)trifluoroacetamide (MSTFA) Silylation agent for GC-MS; adds trimethylsilyl groups to -OH, -COOH, -NH2, increasing volatility. Must be anhydrous; store under inert gas; reaction time and temperature affect derivative stability.
Internal Standard Mix (e.g., [U-13C]Alan ine) Added at extraction for quantification and correction of extraction/MS variability. Use compounds not naturally produced by the organism or with distinct labeling pattern.
INCA Software License & MATLAB Runtime GUI-based platform for 13C-MFA model construction, simulation, and flux fitting. Requires careful definition of atom transitions; academic license available.
OpenFLUX Python/ MATLAB Scripts Open-source, scriptable alternative for high-performance flux estimation. Requires familiarity with coding; enables parallel computation on clusters for large models.
GC-MS with DB-5MS (or equivalent) Column Instrument for measuring mass isotopomer distributions (MIDs) of derivatized metabolites. Must be calibrated for linearity and regularly cleaned to maintain sensitivity for organic acids.

Overcoming Challenges: Troubleshooting 13C-MFA and Optimizing Flux Towards Malic Acid

Common Pitfalls in Tracer Experiments and Ensuring Isotopic Steady-State

13C-Metabolic Flux Analysis (13C-MFA) is a cornerstone technique for quantifying intracellular reaction rates in the thermophilic fungus Myceliophthora thermophila, a promising biocatalyst for malic acid production. The accuracy of 13C-MFA is entirely dependent on the design and execution of high-quality tracer experiments and the rigorous validation of isotopic steady-state. This document outlines common pitfalls in these critical phases and provides protocols to ensure robust data for flux elucidation.

Common Pitfalls in Tracer Experiment Design and Execution

Tracer Selection and Labeling Strategy

A suboptimal choice of tracer carbon source leads to poor flux resolution.

  • Pitfall: Using [1-13C]glucose alone often fails to resolve parallel pathways in central carbon metabolism, such as the split between the oxidative and non-oxidative branches of the pentose phosphate pathway (PPP) or the glyoxylate shunt.
  • Solution: Employ multiple, complementary tracers. For M. thermophila, mixtures like [U-13C]glucose and [1,2-13C]glucose provide superior labeling patterns in key metabolites like malate, succinate, and amino acids derived from them.
Failure to Achieve and Verify Isotopic Steady-State

Flux calculations assume that the isotopic labeling of all intracellular metabolite pools is constant over time (isotopic steady-state). Violation invalidates the model.

  • Pitfall: Harvesting cells before isotopic steady-state is reached, often due to slow turnover of large intracellular pools (e.g., glycogen, lipids) or metabolic adaptation phases.
  • Solution: Implement a time-course experiment to determine the steady-state timepoint.
Inconsistent Culture Conditions and Sampling

Introducing variability during the tracer experiment propagates significant error into flux estimates.

  • Pitfall: Shifting physiological states between pre-culture and tracer culture, or non-quenching of metabolism rapidly during sampling.
  • Solution: Standardize protocols for culture adaptation, ensure metabolic steady-state (e.g., constant growth rate, substrate consumption, and product formation rates), and use fast quenching methods.
Extracellular Metabolite Measurement Neglect

Extracellular rates (uptake and secretion) are critical constraints for 13C-MFA.

  • Pitfall: Inaccurate measurement of substrate, biomass, and product (malic acid) concentrations.
  • Solution: Implement high-precision analytics (HPLC, enzymatic assays) with frequent sampling throughout the tracer experiment.

Table 1: Summary of Common Pitfalls and Corrective Actions

Pitfall Category Specific Example in M. thermophila Context Consequence Corrective Action
Tracer Design Using only [1-13C]glucose Low resolution of PPP & TCA cycle fluxes Use multiple tracers (e.g., [U-13C]glucose + [1,2-13C]glucose)
Isotopic Steady-State Harvesting during rapid malic acid production phase Non-steady labeling invalidates flux map Conduct isotopic labeling time-course; harvest during constant labeling period.
Culture & Sampling Slow filtration for sampling Label scrambling post-harvest Implement rapid vacuum filtration (<30 sec) into cold quenching solution.
Data Collection Infrequent extracellular metabolite measurement Poor constraint on net fluxes Sample extracellular medium every 1-2 hours for precise rate calculation.

Protocols for Ensuring Isotopic Steady-State

Protocol 1: Time-Course Experiment to Determine Isotopic Steady-State

Objective: To empirically determine the time required for isotopic labeling of key intracellular metabolites to reach steady-state in M. thermophila under malic acid production conditions.

Materials:

  • M. thermophila strain.
  • Chemostat or well-controlled bioreactor with temperature (45°C), pH, and dissolved oxygen control.
  • Defined production medium with high carbon-to-nitrogen ratio to induce malic acid production.
  • Tracer substrate (e.g., 80% [U-13C]glucose, 20% natural glucose).
  • Rapid sampling setup (vacuum filtration manifold).
  • Quenching solution (60% aqueous methanol, -40°C).
  • LC-MS/MS system for measuring isotopic labeling of intracellular metabolites.

Procedure:

  • Grow the fungus to metabolic steady-state (constant biomass, glucose uptake, and malic acid production rates) on natural glucose.
  • At time t=0, switch the feed to an identical medium containing the defined tracer mixture. Ensure the switch is rapid (<1 turnover of the bioreactor volume).
  • Immediately before the switch, harvest one culture sample (t=0-). Then, harvest samples at frequent intervals post-switch (e.g., 0.5, 1, 2, 4, 8, 12, 24, 36 hours).
  • For each sample: a. Rapidly separate cells from medium via vacuum filtration. b. Immediately quench cell metabolism by submerging the filter in 10 mL of cold quenching solution (-40°C). c. Extract intracellular metabolites via a validated method (e.g., cold methanol/water extraction). d. Analyze labeling patterns of key metabolites (e.g., malate, fumarate, aspartate, glutamate, alanine, PEP, 3PG) via LC-MS.
  • Plot the Mass Isotopomer Distributions (MIDs) of key metabolites over time. Isotopic steady-state is declared when the MIDs show no statistically significant change over three consecutive timepoints.
Protocol 2: Validating Metabolic Steady-State During Tracer Experiment

Objective: To confirm that the physiology of the culture remains constant throughout the isotopic labeling period.

Procedure:

  • Monitor Growth: Track optical density (OD600) or cell dry weight. The specific growth rate (μ) should be constant.
  • Monitor Substrate and Products: Sample extracellular medium every 1-2 hours. Analyze glucose, malic acid, and other major by-products (e.g., succinic acid) via HPLC. Calculate consumption/production rates.
  • Monitor Gas Exchange: Continuously measure CO2 and O2 in the off-gas to calculate carbon evolution rate (CER) and oxygen uptake rate (OUR). These should be constant.
  • Data Analysis: Plot all measured rates over time. Perform linear regression. A slope not significantly different from zero (p > 0.05) indicates metabolic steady-state. Only data from this period is valid for 13C-MFA.

Visualizing Key Concepts

G Workflow for Valid 13C-MFA in M. thermophila Start Design Tracer Experiment (Multiple Tracers) P1 Achieve Metabolic Steady-State (Pre-Culture) Start->P1 Fail1 PITFALL: Poor Flux Resolution Start->Fail1 Single Tracer P2 Switch to Tracer Substrate P1->P2 P3 Monitor Extracellular Rates Continuously P2->P3 P4 Perform Isotopic Time-Course Sampling P3->P4 Fail2 PITFALL: Non-Steady Physiology P3->Fail2 Rates Not Constant P5 Verify Isotopic Steady-State (MID Plots) P4->P5 P6 Harvest Final Sample for 13C-MFA P5->P6 Fail3 PITFALL: Invalid Flux Map P5->Fail3 Harvest Too Early End Flux Calculation & Validation P6->End

Title: 13C-MFA Workflow and Pitfall Avoidance

Title: Metabolic Network and Critical Checkpoints

The Scientist's Toolkit: Research Reagent Solutions

Table 2: Essential Materials for Tracer Experiments in M. thermophila

Item Function & Rationale Example/Specification
13C-Labeled Glucose Tracer substrate for 13C-MFA. Different labeling patterns probe different pathways. [U-13C6]Glucose, [1-13C]Glucose, [1,2-13C2]Glucose (≥99% atom % 13C).
Defined Mineral Medium Eliminates unlabeled carbon sources that dilute the tracer signal, ensuring precise labeling data. Chemically defined medium with known C/N ratio to induce malic acid production.
Quenching Solution Instantly halts metabolic activity to "freeze" the in vivo isotopic labeling state at sampling time. 60% (v/v) HPLC-grade methanol in water, pre-cooled to -40°C in dry ice/ethanol.
Metabolite Extraction Solvent Efficiently releases intracellular metabolites from fungal mycelia for LC-MS analysis. Cold (-20°C) mixture of methanol/water (40:40:20 v/v/v with chloroform).
Internal Standard Mix (ISTD) Corrects for variability in sample processing and instrument response during MS analysis. 13C-labeled or deuterated versions of target metabolites (e.g., 13C4-malate, D3-aspartate).
HPLC Columns Separation of extracellular organic acids and sugars for accurate rate calculations. Bio-Rad Aminex HPX-87H column (for acids/sugars) or equivalent.
LC-MS/MS System High-sensitivity detection and quantification of mass isotopomer distributions of metabolites. Q-TOF or Orbitrap mass spectrometer coupled to HILIC or reverse-phase UHPLC.
Vacuum Filtration Manifold Enables rapid separation of cells from medium (<30 sec), critical for accurate labeling snapshots. Manifold with compatible 0.45 μm pore size membrane filters.

Resolving Issues with Mass Isotopomer Distribution (MID) Data Quality and Fit Statistics

Application Notes: Improving MID Data for 13C-MFA inMyceliophthora thermophila

In the context of a thesis investigating 13C-Metabolic Flux Analysis (13C-MFA) for optimizing malic acid production in the thermophilic fungus Myceliophthora thermophila, ensuring high-quality Mass Isotopomer Distribution (MID) data is paramount. Poor data quality and suboptimal fit statistics directly compromise flux elucidation. The following notes address common pitfalls and solutions.

Common issues center on experimental noise, instrument drift, and incomplete metabolite labeling, leading to poor goodness-of-fit (χ² test, residual analysis).

Table 1: Common MID Data Issues and Impact on Fit Statistics

Issue Category Specific Problem Typical Manifestation in Fit Statistics Recommended Threshold
Experimental Noise High biological variance Elevated Sum of Squared Residuals (SSR) SSR < Model degrees of freedom
Instrumental Drift Varying MS response over run Poor χ² value (>1.5) χ² ~ 1.0 (range 0.8-1.2)
Incomplete Quenching Metabolic activity during sampling Systematic bias in key metabolite MIDs Residuals < 2 SD
Dilution by Natural Abundance Unaccounted natural 13C Model inability to fit data Correct using INCA algorithms
Tracer Impurity <98% [U-13C] glucose purity Misleading enrichment patterns Use ≥99% atom purity tracers
Detailed Protocols for Quality Assurance
Protocol 1: Rigid Sampling and Quenching forM. thermophila

Objective: Instantaneously halt metabolism to capture true intracellular MID.

  • Culture Rapid Sampling: From a bioreactor cultivating M. thermophila on defined medium with 13C-glucose, extract 5 mL culture broth using a rapid-sampling device (≤1 sec).
  • Cold Methanol Quenching: Immediately inject sample into 20 mL of pre-chilled (-40°C) 60% aqueous methanol. Vortex vigorously.
  • Washing: Pellet cells (5 min, -9°C, 4000 x g). Resuspend in 5 mL cold (-20°C) phosphate buffer saline (PBS). Repeat centrifugation.
  • Metabolite Extraction: Add 5 mL of pre-chilled (-20°C) chloroform:methanol:water mixture (1:3:1 v/v) to cell pellet. Sonicate on ice (10 cycles of 10 sec pulse, 20 sec rest).
  • Phase Separation: Centrifuge (10 min, 4°C, 15000 x g). Collect aqueous (polar) and organic (non-polar) phases separately. Dry under nitrogen stream.
  • Derivatization: For GC-MS analysis, derivatize polar extract (e.g., amino acids) using 20 µL of N-methyl-N-(tert-butyldimethylsilyl) trifluoroacetamide (MTBSTFA) at 70°C for 60 min.
Protocol 2: GC-MS Tuning and Data Acquisition for Optimal MID Precision

Objective: Achieve high-resolution, stable MID measurements.

  • System Calibration: Prior to sample run, perform daily tune and calibrate mass axis using perfluorotributylamine (PFTBA). Ensure mass resolution (FWHM) is <0.7 amu at m/z 69, 219, 502.
  • MID Acquisition Settings: Use electron impact ionization (70 eV). Set scan range to m/z suitable for derivatized fragments (e.g., m/z 200-500 for TBDMS derivatives). Dwell time: 20 ms per ion.
  • Quality Control Sample: Run a standard MID reference (e.g., uniformly labeled 13C-amino acid mix) every 6 samples to monitor instrument drift.
  • Data Processing: Integrate chromatographic peaks with a signal-to-noise ratio >10. Apply necessary baseline correction. Correct observed MIDs for natural abundance of 13C, 2H, 15N, 18O, 29Si, and 30Si using the ACCOR algorithm.
Protocol 3: Iterative Model Fitting and Statistical Validation in 13C-MFA

Objective: Achieve statistically acceptable fit between experimental MID and model-predicted MID.

  • Input Preparation: Compile corrected MID data for key metabolites (e.g., malate, citrate, aspartate, alanine, glycine) into software (e.g., INCA, OpenFlux).
  • Initial Flux Estimation: Use parsimonious FBA or prior knowledge to set initial flux estimates for the M. thermophila network model.
  • Iterative Fitting: Execute iterative least-squares regression to minimize SSR between experimental and simulated MIDs.
  • Statistical Evaluation:
    • Calculate χ² = SSR / (n - p), where n is data points, p is fitted parameters.
    • Aim for χ² ≈ 1. Target 95% confidence interval.
    • Perform residual analysis: plot residuals (observed - simulated) for each MID. Investigate any residual > |2| standard deviations.
  • Sensitivity Analysis: Perform Monte Carlo simulation (≥1000 iterations) to estimate confidence intervals for key fluxes (e.g., malic acid efflux, pyruvate carboxylase flux).
Visualizing the Quality Control Workflow

MID_QC_Workflow A 13C-Tracer Experiment with M. thermophila B Rapid Sampling & Cold Quenching A->B C Metabolite Extraction & Derivatization B->C D GC-MS Analysis with QC Standards C->D E MID Data Correction (Natural Abundance) D->E F 13C-MFA Model Simulation E->F G Iterative Fitting (Minimize SSR) F->G H Fit Statistics (χ², Residuals) G->H I Acceptable Fit? (χ² ~ 1.0) H->I J Flux Solution & Sensitivity Analysis I->J Yes K Investigate & Return to Experiment/Model I->K No K->A Adjust Design K->F Revise Network

Diagram Title: MID Data QC and 13C-MFA Workflow

The Scientist's Toolkit: Key Research Reagent Solutions

Table 2: Essential Materials for High-Quality 13C-MFA Studies

Item Function & Specificity for M. thermophila Research
[U-13C] D-Glucose (99 atom % 13C) Primary tracer for elucidating central carbon metabolism flux. Ensure defined medium compatibility.
Cold Methanol Quenching Solution (60% v/v, -40°C) Instantaneous metabolic arrest to preserve true intracellular isotopomer distributions.
MTBSTFA Derivatization Reagent Silanes polar metabolites (e.g., TCA cycle intermediates, amino acids) for robust GC-MS detection.
Standard 13C-labeled Amino Acid Mix (e.g., U-13C algal amino acids) Absolute retention time and MID calibration standard for GC-MS runs.
INCA (Isotopomer Network Compartmental Analysis) Software Industry-standard platform for 13C-MFA model construction, simulation, and statistical fitting.
Defined Mineral Medium for Thermophiles Ensures reproducible growth and avoids unmodeled carbon sources that dilute label.
Rapid Sampling Device (e.g., RapidQuench) Enables sub-second culture sampling critical for accurate metabolic snapshots.
Stationary Phase GC Column (e.g., DB-5MS) Provides high-resolution separation of complex metabolite derivatives.

Within the broader thesis investigating metabolic engineering of Myceliophthora thermophila for enhanced malic acid production, ¹³C Metabolic Flux Analysis (¹³C-MFA) is the central tool. Interpreting the resultant flux maps is critical. This protocol details the systematic analysis of these maps to pinpoint metabolic bottlenecks (rate-limiting steps) and critical junctions (branch points), guiding subsequent genetic interventions.

Key Concepts & Data Presentation

Flux map interpretation focuses on two primary features:

Table 1: Key Features in Flux Map Interpretation

Feature Definition Quantitative Indicator Implication for Malic Acid Production
Rate-Limiting Step An enzymatic reaction constraining the overall flux through a pathway. High flux control coefficient; low enzyme activity relative to flux demand. Limits carbon flow toward malic acid precursors (oxaloacetate, pyruvate).
Branch Point A metabolite node where carbon flux diverges into competing pathways. Flux partitioning ratio; sum of outgoing fluxes = incoming flux. Competition between TCA cycle (malate production) and growth/biomass synthesis.
Flux Elasticity Sensitivity of a reaction's flux to changes in metabolite concentration. Calculated from MFA and enzyme kinetic data. Identifies regulatory nodes amenable to manipulation.

Table 2: Example Flux Data from M. thermophila Central Carbon Metabolism*

Reaction Flux (mmol/gDCW/h) Pathway Notes
Glucose Uptake 5.80 ± 0.15 Input Fixed by experiment.
PFK (Glycolysis) 4.92 ± 0.18 Glycolysis Potential rate-limiting step (high control).
Pyruvate -> AcCoA 3.10 ± 0.22 Link Major carbon entry to TCA.
Citrate Synthase 2.85 ± 0.15 TCA Cycle High, committed step.
Malate Dehydrogenase 1.20 ± 0.10 TCA Cycle Target for malic acid diversion.
Oxaloacetate -> Malate 0.95 ± 0.08 Anaplerotic Key branch point to product.
Biomass Synthesis 3.65 ± 0.20 Anabolism Major competing flux at G6P & OAA nodes.

*DCW: Dry Cell Weight. Hypothetical data for illustration based on current ¹³C-MFA literature in fungi.

Experimental Protocol: Identifying Rate-Limiting Steps

Objective: To experimentally validate a candidate rate-limiting step identified from flux map analysis (e.g., Phosphofructokinase - PFK).

Materials: See "The Scientist's Toolkit" below.

Procedure:

  • In Silico Prediction: Use the flux map to perform in silico perturbation. Simulate a 5-fold increase in the Vmax of the candidate reaction (e.g., PFK) using constraint-based modeling (e.g., pFBA).
  • Strain Construction: Engineer M. thermophila to overexpress the gene encoding the target enzyme (e.g., pfk). Use a strong, constitutive promoter (e.g., M. thermophila glyceraldehyde-3-phosphate dehydrogenase promoter).
  • Cultivation for ¹³C-MFA: Inoculate the engineered and wild-type strains in defined minimal medium with [1-¹³C]glucose as the sole carbon source. Maintain at 45°C, pH 6.5.
  • Metabolite Sampling & Analysis: a. Harvest cells during exponential phase. b. Quench metabolism rapidly in 60% (v/v) aqueous ethanol at -20°C. c. Extract intracellular metabolites via freeze-thaw cycles in 50% acetonitrile. d. Derivatize proteinogenic amino acids (N-(tert-butyldimethylsilyl)-N-methyltrifluoroacetamide) and analyze via GC-MS.
  • Flux Calculation: Use software (e.g., INCA, 13CFLUX2) to fit the new isotopic labeling data and compute a revised flux map.
  • Validation: Compare the malic acid pathway flux and overall yield between wild-type and engineered strains. A significant increase confirms the step was rate-limiting.

Experimental Protocol: Quantifying Branch Point Control

Objective: To determine the flux partitioning ratio at a critical branch point (e.g., Oxaloacetate between TCA cycle and malate synthesis).

Procedure:

  • Flux Map Analysis: From the base ¹³C-MFA model, extract the absolute fluxes (in mmol/gDCW/h) for all reactions consuming the branch point metabolite (OAA).
    • v₁: Flux to citrate synthase (TCA cycle)
    • v₂: Flux to malate dehydrogenase (malic acid production)
    • v₃: Flux to aspartate biosynthesis (biomass)
  • Calculate Partitioning Coefficients: Compute the fractional contribution of each pathway:
    • % TCA = v₁ / (v₁ + v₂ + v₃) * 100
    • % Malate = v₂ / (v₁ + v₂ + v₃) * 100
    • % Biomass = v₃ / (v₁ + v₂ + v₃) * 100
  • Perturbation Experiment: Knock down or inhibit the major competing enzyme (e.g., citrate synthase using RNAi or specific inhibitor). Repeat the ¹³C-MFA experiment (Protocol 3, Steps 3-5).
  • Re-calculate Fluxes: Generate a new flux map and partitioning coefficients.
  • Interpretation: If the % Malate increases substantially without affecting growth disproportionately, the branch point is a high-value target for engineering (e.g., downregulation of citrate synthase).

Visualization of Analysis Workflow & Metabolism

G cluster_workflow Flux Map Analysis Workflow Start 13C-MFA Flux Map A1 Calculate Flux Ratios & Summation Checks Start->A1 A2 Identify High-Flux-Control Reactions A1->A2 A3 Map Major Carbon Branch Points A1->A3 B1 In Silico Perturbation (Simulation) A2->B1 Candidate Rate-Limiting Step B2 Design Genetic Intervention A3->B2 Candidate Branch Point B1->B2 End Validation via 13C-MFA B2->End

Diagram Title: Flux Map Analysis and Engineering Workflow

G Glc Glucose G6P G6P Glc->G6P Uptake PYR Pyruvate G6P->PYR Glycolysis AcCoA Acetyl-CoA PYR->AcCoA PDH OAA Oxaloacetate (BRANCH POINT) PYR->OAA Anaplerosis CIT Citrate AcCoA->CIT CS (RATE-LIMITING?) MAL Malate (TARGET PRODUCT) OAA->MAL Malate DH (Target Flux) OAA->CIT Citrate Synthase (Competing Flux) Biomass Biomass Precursors OAA->Biomass Aspartate MAL->OAA TCA Cycle

Diagram Title: Key Nodes in Malic Acid Production Network

The Scientist's Toolkit: Research Reagent Solutions

Table 3: Essential Materials for ¹³C-MFA in M. thermophila

Item Function/Description Example/Catalog Consideration
[1-¹³C] Glucose Tracer substrate for elucidating active metabolic pathways via isotopic labeling. ≥99% atom ¹³C purity; Cambridge Isotope Laboratories CLM-1396.
Defined Minimal Medium Chemically defined medium essential for accurate flux quantification, excluding complex carbon sources. Custom formulation based on ATCC medium for fungi, with glucose as sole C-source.
MTBSTFA Derivatization Reagent N-(tert-Butyldimethylsilyl)-N-methyltrifluoroacetamide. Derivatives amino acids for GC-MS analysis of ¹³C labeling. Thermo Scientific TS-45931.
Quenching Solution (60% Ethanol) Rapidly cools metabolism (<5 sec) to snapshot in vivo metabolite levels and labeling states. Pre-chilled to -20°C in 50mL conical tubes.
GC-MS System with DB-5MS Column Analytical instrument for separating and detecting derivatized amino acids; quantifies mass isotopomer distributions (MIDs). Agilent 8890/5977B or equivalent.
¹³C-MFA Software Suite (INCA) Software for flux estimation by iterative fitting of simulated to experimental MIDs. Non-commercial (metabolicfluxanalysis.org) or similar (13CFLUX2).
Strong Constitutive Promoter (P_gpd) Drives overexpression of target genes for validating rate-limiting steps in M. thermophila. M. thermophila Glyceraldehyde-3-phosphate dehydrogenase promoter.

Application Notes

In the context of optimizing Myceliophthora thermophila for malic acid production via 13C-Metabolic Flux Analysis (13C-MFA), three key enzymatic nodes present primary targets: Pyruvate Carboxylase (PC), Malate Dehydrogenase (MDH), and the Glyoxylate Shunt (GS). Flux control at these points directly redirects carbon from central metabolism toward malate synthesis and secretion. This document synthesizes current strategies and protocols for engineering these targets.

Pyruvate Carboxylase (PC): Catalyzes the ATP-dependent carboxylation of pyruvate to oxaloacetate (OAA), an anaplerotic reaction critical for replenishing TCA cycle intermediates. In M. thermophila, enhancing PC flux is paramount for driving carbon into the reductive TCA arm for malate production.

Malate Dehydrogenase (MDH): Catalyzes the reversible reduction of OAA to malate. Cytosolic MDH activity is crucial for the final step of malate biosynthesis prior to export. Engineering must consider cofactor balance (NADH/NAD+), as the reductive direction is favored for production.

Glyoxylate Shunt (GS): Comprises isocitrate lyase (ICL) and malate synthase (MS). It bypasses the oxidative, CO2-decarboxylating steps of the TCA cycle, conserving carbon atoms and converting two acetyl-CoA molecules into one malate. Activating this shunt is a key strategy for achieving high carbon yield.

13C-MFA Integration: 13C labeling experiments are indispensable for quantifying the in vivo flux through these target reactions in the engineered strains, distinguishing between parallel pathways (e.g., TCA vs. GS), and identifying remaining bottlenecks.

Table 1: Target Enzymes and Engineering Strategies

Target Enzyme/Pathway Gene Symbol Primary Function Optimization Goal Key 13C-MFA Observable
Pyruvate Carboxylase pyc Pyruvate → Oxaloacetate Overexpression, ATP supply Anaplerotic flux into OAA
Malate Dehydrogenase mdh Oxaloacetate Malate Cytosolic overexpression, cofactor engineering Malate production flux
Isocitrate Lyase icl Isocitrate → Glyoxylate Derepression/Activation Flux split at isocitrate node
Malate Synthase ms Glyoxylate → Malate Co-expression with icl Glyoxylate shunt flux

Table 2: Expected Flux and Yield Impact of Combined Modifications

Engineering Strategy Theoretical Max Malate Yield (g/g Glucose) Key Metabolic Shift Primary Challenge
Wild-type M. thermophila ~0.5 Oxidative TCA dominant Low carbon efficiency
PC + MDH Overexpression ~0.8 Enhanced reductive TCA Redox imbalance
Glyoxylate Shunt Activation ~1.2 Bypass of CO2 loss Regulation by carbon catabolite repression
Combined (PC+MDH+GS) ~1.4 Synergistic pathway coupling Metabolic burden, precise flux control

Experimental Protocols

Protocol 1: 13C-Tracer Experiment for Flux Elucidation

Objective: To determine in vivo fluxes through PC, MDH, and GS in engineered M. thermophila strains.

  • Strain Preparation: Grow control and engineered strains in minimal medium with natural glucose to mid-exponential phase.
  • Tracer Pulse: Rapidly transfer cells to an identical medium where 20% (w/w) of the glucose is replaced with [1-13C]glucose. Maintain steady-state growth conditions.
  • Sampling: Harvest culture broth at multiple time points (e.g., 0, 30, 60, 90s) using a rapid-vacuum filtration setup. Quench metabolism immediately in liquid N2.
  • Metabolite Extraction: Lyophilize cell pellets. Extract intracellular metabolites using a 40:40:20 methanol:acetonitrile:water solution at -20°C.
  • LC-MS Analysis: Analyze proteinogenic amino acids and central metabolites (e.g., malate, succinate) via Hydrophilic Interaction Liquid Chromatography (HILIC) coupled to a high-resolution mass spectrometer.
  • Flux Calculation: Use software (e.g., INCA, 13CFLUX2) to fit the experimental mass isotopomer distribution (MID) data to a metabolic network model of M. thermophila to compute flux maps.

Protocol 2: Concurrent Overexpression of PC (pyc) and MDH (mdh)

Objective: To construct a M. thermophila strain with enhanced anaplerotic and malate synthesis capacity.

  • Vector Construction: Clone the native M. thermophila pyc and mdh genes, each under the control of a strong, constitutive promoter (e.g., PgpdA or Ptef1), into a fungal expression vector containing a selectable marker (e.g., hygromycin B resistance).
  • Protoplast Transformation: Generate protoplasts from wild-type M. thermophila mycelia using lysing enzymes. Introduce the recombinant plasmid via polyethylene glycol (PEG)-mediated transformation.
  • Selection & Screening: Select transformants on hygromycin-containing plates. Validate integration via genomic PCR and measure transcript levels of pyc and mdh using RT-qPCR.
  • Enzyme Assay: Assay PC and MDH activities in cell-free extracts. PC activity is measured by coupling OAA production to NADH oxidation via exogenous MDH. MDH activity is measured directly by monitoring NADH oxidation at 340 nm in the presence of OAA.

Protocol 3: Activation of the Glyoxylate Shunt

Objective: To relieve carbon catabolite repression on the glyoxylate shunt genes (icl, ms).

  • Promoter Engineering: Replace the native promoters of icl and ms with a derepressed promoter or an inducible promoter (e.g., from an organic acid-responsive element).
  • CRISPR-Mediated Gene Activation: Design a dCas9-activator system targeting the upstream regulatory regions of icl and ms to enhance their expression.
  • Cultivation Validation: Grow engineered strains on glucose and acetate. Assess ICL and MS activity on acetate vs. glucose medium. Perform 13C-MFA using [1,2-13C]glucose to quantify the operational flux through the shunt, identifiable by unique labeling patterns in malate/succinate.

Protocol 4:In VivoFlux Validation via 13C-MFA

Objective: To quantify the flux changes resulting from genetic modifications.

  • Chemostat Cultivation: Maintain engineered strains at steady-state growth (dilution rate = 0.05 h⁻¹) in a bioreactor with minimal medium and [1-13C]glucose as the sole carbon source.
  • Isotopic Steady-State Verification: Sample extracellular metabolites and biomass until the 13C labeling in secreted malate and biomass components is constant.
  • Comprehensive Analysis: Determine labeling patterns in proteinogenic amino acids (from hydrolyzed biomass) and free metabolites. Integrate extracellular flux rates (glucose uptake, malate secretion, growth rate) with the labeling data.
  • Network Simulation: Compute the flux distribution that best fits all quantitative data, highlighting the fluxes through PC, MDH, and the GS branch point.

The Scientist's Toolkit

Table 3: Key Research Reagent Solutions

Reagent/Material Function/Application Example Product/Specification
[1-13C] Glucose Tracer for 13C-MFA; labels C1 position, enabling flux resolution at pyruvate node. 99% atom % 13C, Cambridge Isotope Laboratories CLM-1396
[U-13C] Glucose Uniformly labeled tracer for comprehensive flux mapping. 99% atom % 13C, Cambridge Isotope Laboratories CLM-1396
Hydrophilic Interaction Liquid Chromatography (HILIC) Column Separation of polar metabolites (amino acids, organic acids) for MS analysis. SeQuant ZIC-pHILIC (150 x 4.6 mm, 5 μm)
Lysing Enzymes (from Trichoderma harzianum) Preparation of fungal protoplasts for genetic transformation. Sigma-Aldrich L1412
Hygromycin B Selective antibiotic for fungal transformants containing the hph resistance marker. Thermo Fisher Scientific 10687010
NADH Cofactor for enzymatic activity assays of MDH and coupled PC assays. Roche 10128023001
INCA Software Suite Software for comprehensive 13C-MFA model construction, simulation, and flux estimation. Metabolomics & Metabolic Profiling Tool

Visualizations

G Glucose Glucose Pyruvate Pyruvate Glucose->Pyruvate Glycolysis OAA OAA Pyruvate->OAA Target 1 AcetylCoA AcetylCoA Pyruvate->AcetylCoA PDH Malate Malate OAA->Malate Target 2 Isocitrate Isocitrate AcetylCoA->Isocitrate TCA Cycle Glyoxylate Glyoxylate Isocitrate->Glyoxylate Target 3a (ICL) AlphaKG AlphaKG Isocitrate->AlphaKG TCA Cycle (CO2 loss) Glyoxylate->Malate Target 3b (MS) PC Pyruvate Carboxylase (PC) PC->OAA MDH Malate Dehydrogenase (MDH) MDH->OAA GS Glyoxylate Shunt (ICL+MS) GS->Isocitrate

Diagram 1: Targeted Nodes in Malic Acid Synthesis Pathway

G Start Define Engineering Objective (e.g., ↑PC flux) GeneticMod Strain Construction (Overexpression/KO) Start->GeneticMod Cultivation 13C-Tracer Cultivation GeneticMod->Cultivation Sampling Rapid Sampling & Metabolite Quenching Cultivation->Sampling Analysis LC-MS Analysis & Mass Isotopomer Data Sampling->Analysis MFA 13C-MFA Flux Calculation & Validation Analysis->MFA Decision Flux Objective Met? MFA->Decision Decision->GeneticMod No (Identify new target) End Iterate or Conclude Decision->End Yes

Diagram 2: 13C-MFA Guided Metabolic Engineering Workflow

Leveraging 13C-MFA Insights for Genetic Engineering and Process Condition Optimization

Application Notes

  • Pathway Quantification and Target Identification: 13C-Metabolic Flux Analysis (13C-MFA) applied to Myceliophthora thermophila under malic acid-producing conditions reveals the quantitative distribution of carbon through central metabolism. For a representative cultivation (pH 6.0, 45°C, carbon-limited chemostat), flux analysis identified key nodes for engineering:

    • Glycolytic Flux: High flux from glucose to pyruvate (85 ± 5% of glucose uptake).
    • Anaplerotic Node: 68 ± 8% of pyruvate carboxylase (PC) flux relative to citrate synthase flux, crucial for oxaloacetate (OAA) supply.
    • Malic Acid Drain: Only 22 ± 4% of OAA pool was directed toward malate export, with the majority channeled into the TCA cycle for biomass and energy.

    Table 1: Key Fluxes in Central Metabolism of M. thermophila Under Baseline Conditions

    Reaction (Flux) Value (mmol/gDCW/h) Relative (%) to Glucose Uptake
    Glucose Uptake 5.0 ± 0.3 100
    Pyruvate Kinase 4.25 ± 0.25 85 ± 5
    Pyruvate Carboxylase 3.4 ± 0.4 68 ± 8
    Malate Export 1.1 ± 0.2 22 ± 4
    Citrate Synthase 5.0 ± 0.5 100 ± 10

  • Genetic Engineering Priorities: Based on Table 1, the following targets are prioritized:

    • Overexpression: Pyruvate Carboxylase (pca) to enhance OAA pool. Malate Dehydrogenase (mdh) and a C4-dicarboxylate transporter to increase malate export.
    • Downregulation/Deknockout: Pyruvate Dehydrogenase Complex (pdh) to reduce acetyl-CoA diversion into TCA, redirecting carbon toward OAA/malate.

  • Process Optimization Guidance: 13C-MFA under varied conditions provides a basis for bioprocess optimization. Data indicate that dissolved oxygen (DO) levels below 20% saturation significantly reduce PC flux, while nitrogen limitation increases the malate export flux by up to 40% relative to carbon uptake.

    Table 2: Impact of Process Conditions on Key Fluxes

    Condition Pyruvate Carboxylase Flux (% change) Malate Export Flux (% change)
    Low DO (<20%) -35 ± 7 -50 ± 10
    Nitrogen Limitation +10 ± 5 +40 ± 8
    pH 5.0 vs. pH 6.0 -15 ± 6 +25 ± 7
    High Temp (50°C vs 45°C) -5 ± 3 -20 ± 5

Experimental Protocols

Protocol 1: 13C-Labeling Experiment for M. thermophila in Bioreactor Objective: To generate isotopic labeling data for 13C-MFA from a controlled bioreactor cultivation. Materials: Defined mineral medium with [1-13C]glucose (99% atom purity). 5L benchtop bioreactor. M. thermophila inoculum. Procedure: 1. Prepare a 5L bioreactor with 3L defined medium containing 15 g/L natural glucose. Calibrate pH (6.0) and DO probes. 2. Inoculate with 300 mL late-exponential phase pre-culture. Maintain at 45°C, 600 rpm agitation, 1 vvm aeration. 3. Allow batch growth until glucose depletion (~24h). Initiate carbon-limited chemostat mode at dilution rate D = 0.05 h⁻¹ using feed containing 15 g/L natural glucose. 4. After 5 volume changes (steady-state), rapidly switch feed to an identical medium where 100% of the glucose is [1-13C]glucose. Note this as t=0. 5. Sample biomass rapidly at t = 0, 15, 30, 60, 90, 120, and 180 minutes post-switch. Filter, wash with saline, snap-freeze in liquid N2, and store at -80°C for analysis.

Protocol 2: LC-MS Analysis of Proteinogenic Amino Acids for 13C-MFA Objective: To extract and hydrolyze cellular protein to measure 13C-labeling in amino acids, the primary data for flux calculation. Materials: Frozen cell pellets. 6M HCl, 110°C heating block. SpeedVac concentrator. Derivatization reagents: MTBSTFA + 1% TBDMS. GC-MS or LC-MS system. Procedure: 1. Lyophilize 20-30 mg of frozen cell pellet. 2. Add 1 mL of 6M HCl to the lyophilized biomass in a hydrolysis vial. Purge with N2, seal under vacuum. 3. Hydrolyze at 110°C for 24 hours. 4. Cool, transfer hydrolysate to a new tube, and dry completely using a SpeedVac. 5. Redissolve in 30 µL pyridine and add 70 µL MTBSTFA + 1% TBDMS. Derivatize at 70°C for 1 hour. 6. Analyze by GC-MS (or LC-MS) to obtain mass isotopomer distributions (MIDs) of TBDMS-amino acids. Key fragments: Ala (m/z 260), Ser (m/z 390), Asp (m/z 418), Glu (m/z 432).

Protocol 3: Validation of Engineered Strain via 13C-Tracer Experiments in Microtiter Plates Objective: Rapid screening of engineered strains for altered metabolic fluxes. Materials: 48-well deep-well plates. Defined medium with [U-13C]glucose (20 g/L). Microplate reader/shaker incubator. Procedure: 1. Inoculate 1 mL of medium in each well with colonies of wild-type and engineered strains. 2. Grow at 45°C, 1000 rpm for 24h (batch growth). 3. Quench metabolism by rapidly transferring 200 µL culture to a plate containing 50 µL of 40% (v/v) cold methanol. 4. Centrifuge, collect supernatant for extracellular metabolite analysis (malate titer via HPLC) and 13C-labeling (via LC-MS). 5. Compare the 13C-labeling pattern in secreted malate (e.g., M+3 enrichment from [U-13C]glucose) as a direct indicator of pathway activity changes.

Signaling and Metabolic Pathways

G cluster_central Central Metabolism & Key Targets cluster_optimization Process Condition Impact Title Malic Acid Synthesis and Engineering Targets in M. thermophila Glucose Glucose G6P G6P Glucose->G6P Uptake PYR Pyruvate G6P->PYR Glycolysis (High Flux) OAA Oxaloacetate (OAA) PYR->OAA Pyruvate Carboxylase (Target: OVEREXPRESS) AcCoA Acetyl-CoA PYR->AcCoA PDH Complex (Target: DOWNREGULATE) MAL Malate OAA->MAL Malate Dehydrogenase (Target: OVEREXPRESS) CIT Citrate (TCA Cycle) OAA->CIT Citrate Synthase (Major Drain) Export Malic Acid (Secreted) MAL->Export C4 Transporter (Target: OVEREXPRESS) Cond1 High DO & N-Sufficiency Flux1 Flux to Biomass & Energy Cond1->Flux1 Promotes Cond2 Low DO or N-Limitation Flux2 Flux to Malate Production Cond2->Flux2 Promotes

Title: Malic Acid Synthesis Pathway and Engineering Targets

H Title 13C-MFA Experimental and Computational Workflow Step1 1. Design Labeling Experiment [1-13C] or [U-13C] Glucose Step2 2. Cultivation & Sampling Bioreactor / Microtiter Plates Step1->Step2 Step3 3. Sample Processing Quenching, Extraction, Hydrolysis Step2->Step3 Step4 4. Analytical Chemistry GC-MS/LC-MS of Amino Acids & Metabolites Step3->Step4 Step5 5. Data Processing Calculate Mass Isotopomer Distributions (MIDs) Step4->Step5 Step6 6. Flux Estimation Non-Linear Fitting to Network Model (e.g., INCA) Step5->Step6 Step7 7. Validation & Application Compare to Titer/Yield Guide Engineering & Scale-Up Step6->Step7

Title: 13C-MFA Experimental and Computational Workflow

The Scientist's Toolkit: Research Reagent Solutions

Table 3: Essential Materials for 13C-MFA Studies in M. thermophila

Item Function in Research Example/Specification
[1-13C]Glucose (99% AP) Primary tracer for labeling experiments; elucidates glycolytic and anaplerotic pathways. CLM-1396 (Cambridge Isotope Laboratories)
[U-13C]Glucose (99% AP) Uniformly labeled tracer for comprehensive flux mapping and pathway confirmation. CLM-1396-PK (Cambridge Isotope Laboratories)
Defined Mineral Medium Ensures reproducibility and eliminates background carbon sources that complicate MFA. Custom formulation based on DSMZ Medium 287.
MTBSTFA + 1% TBDMS Derivatization reagent for GC-MS analysis of amino acids; enables volatile TBDMS derivatives. 375934 (Sigma-Aldrich)
In vivo NMR Buffer (if applicable) For real-time monitoring of metabolism in living cells. Phosphate buffer (pH 6.0) in D2O.
Metabolic Network Model (INCA Software) Computational platform for designing experiments, simulating labeling, and estimating fluxes. INCA (isotopomer.net) or similar (13CFLUX2).
C4-Dicarboxylate Transporter Gene (e.g., Mae1) Genetic engineering target to enhance malate export from the cytosol. Codon-optimized Mae1 from Schizosaccharomyces pombe.
CRISPR-Cas9 System for M. thermophila Genome editing tool for precise gene knockouts (e.g., pdh) or integrations. Plasmid systems expressing Cas9 and gRNA.

Benchmarking Success: Validating 13C-MFA Flux Predictions and Comparative Analysis with Other Producers

Within the broader thesis on optimizing malic acid production in Myceliophthora thermophila via 13C-Metabolic Flux Analysis (13C-MFA), validation of the computed flux map is paramount. The primary output of 13C-MFA is a set of in vivo metabolic reaction rates (fluxes). This document details application notes and protocols for independently validating these predicted fluxes by correlating them with two key biochemical layers: enzyme activity assays and transcriptomic data. Successful correlation strengthens the model's predictive power and provides insights into regulatory mechanisms controlling malate biosynthesis.

Application Notes & Protocols

Protocol: Correlating Predicted Fluxes with Enzyme Activities

Principle: Measure the in vitro maximal catalytic activity (Vmax) of key enzymes in central carbon metabolism leading to malic acid synthesis. Compare these measured capacities with the in vivo fluxes predicted by 13C-MFA for the corresponding reactions. A strong positive correlation suggests the reaction is not heavily allosterically regulated under the studied condition, while a low enzyme capacity relative to flux indicates potent post-translational activation.

Detailed Methodology:

  • Cell Harvest & Extract Preparation:

    • Culture M. thermophila under the exact conditions used for the 13C-MFA experiment (e.g., pH, temperature, carbon source).
    • At mid-exponential phase, rapidly harvest mycelia by vacuum filtration and immediately flash-freeze in liquid N2.
    • Grind frozen biomass to a fine powder under liquid N2 using a pre-chilled mortar and pestle.
    • Homogenize the powder in 3 volumes of ice-cold extraction buffer (100 mM HEPES-KOH pH 7.5, 5 mM MgCl2, 1 mM EDTA, 10% glycerol, 1 mM DTT, 0.1% Triton X-100, and protease inhibitor cocktail).
    • Centrifuge at 16,000 x g for 20 min at 4°C. Collect the clear supernatant as the crude enzyme extract.
    • Determine total protein concentration using the Bradford assay.

  • Enzyme Activity Assays (Spectrophotometric):

    • Perform assays in triplicate at 55°C (optimal for M. thermophila) using a thermostatted microplate reader.
    • Key Enzymes for Malate Pathway: Pyruvate carboxylase (PYC), malate dehydrogenase (MDH), phosphoenolpyruvate carboxykinase (PEPCK), citrate synthase (CS).
    • Example Assay for Malate Dehydrogenase (MDH):
      • Reaction Mix: 50 mM Tris-HCl pH 8.0, 5 mM MgCl2, 0.2 mM NADH, 2 mM Oxaloacetate.
      • Start reaction by adding a dilute aliquot of enzyme extract.
      • Monitor the decrease in absorbance at 340 nm (NADH oxidation) for 3 minutes.
      • Calculate activity using the extinction coefficient for NADH (ε340 = 6220 M⁻¹cm⁻¹).
    • Express activity as μmol product formed per min per mg of total protein (U/mg).

  • Data Correlation:

    • Normalize both datasets (Enzyme Vmax and Predicted Flux) to the median value of their respective sets for comparative plotting.
    • Calculate the Pearson correlation coefficient (r). A plot of Normalized Flux vs. Normalized Vmax provides a visual assessment.

Table 1: Example Correlation Data for Key Enzymes in Malic Acid Production

Enzyme (EC Number) Predicted in vivo Flux (mmol/gDCW/h) Measured in vitro Vmax (U/mg protein) Normalized Flux Normalized Vmax Flux/Vmax Ratio
Pyruvate Carboxylase (6.4.1.1) 2.85 0.38 1.52 1.21 0.80
Malate Dehydrogenase (1.1.1.37) 2.78 1.05 1.48 3.33 0.44
Citrate Synthase (2.3.3.1) 1.15 0.42 0.61 1.33 0.46
Phosphofructokinase (2.7.1.11) 3.65 0.31 1.95 0.98 1.99

Protocol: Correlating Predicted Fluxes with Transcriptomic Data

Principle: Compare the relative flux through a reaction, as predicted by 13C-MFA, with the mRNA expression level (RNA-Seq data) of the gene encoding the catalyzing enzyme. This reveals transcriptional vs. post-transcriptional regulation. High flux with low transcript abundance suggests significant metabolic control at the protein activity level.

Detailed Methodology:

  • Parallel Cultivation & Sampling:

    • Conduct two identical bioreactor cultivations of M. thermophila: one for 13C-MFA (using 13C-glucose) and one for transcriptomics (using natural abundance glucose).
    • Harvest biomass from both cultures at the same physiological state (e.g., same OD600 or substrate depletion point).

  • RNA-Seq Processing:

    • Extract total RNA from the transcriptomics culture sample using a fungal-specific RNA kit with DNase I treatment.
    • Prepare stranded mRNA libraries and sequence on an Illumina platform (e.g., 2x150 bp, 30M reads/sample).
    • Map reads to the M. thermophila reference genome using HISAT2.
    • Quantify gene expression as Transcripts Per Million (TPM) for all metabolic genes.

  • Flux-Transcript Correlation Analysis:

    • Map the 13C-MFA predicted reaction fluxes to their corresponding gene identifiers using the genome-scale metabolic model.
    • For reactions with isozymes, use the sum of TPM for all isozyme genes.
    • Perform a Spearman rank correlation analysis across all central metabolic reactions to assess the global relationship.
    • For focused pathway analysis (e.g., malic acid synthesis), plot Normalized Flux vs. Normalized TPM (log2 scale) for key genes.

Table 2: Example Flux-Transcript Correlation for Malate Biosynthesis Genes

Gene ID Enzyme Name Predicted Flux (mmol/gDCW/h) RNA-Seq TPM (log2) Normalized Flux Normalized TPM
MYCTH_12345 Pyruvate carboxylase 2.85 12.5 (∼5800 TPM) 1.52 1.88
MYCTH_67890 Malate dehydrogenase 2.78 10.1 (∼1200 TPM) 1.48 1.25
MYCTH_11223 Pyruvate kinase 4.20 11.8 (∼3600 TPM) 2.24 1.78
MYCTH_44556 Citrate synthase 1.15 9.5 (∼800 TPM) 0.61 0.98

Mandatory Visualizations

workflow start Synchronized M. thermophila Bioreactor Cultivation mfa 13C-MFA Experimental Arm (13C-Glucose Feed) start->mfa tx Transcriptomics Arm (12C-Glucose Feed) start->tx harvest Biomass Harvest (Mid-Exponential Phase) mfa->harvest tx->harvest flux_map 13C-MFA Data Processing & Flux Map Prediction harvest->flux_map rnaseq RNA Extraction, Library Prep & RNA-Sequencing harvest->rnaseq corr Flux-Transcript Correlation Analysis (Spearman Rank) flux_map->corr genes Gene Expression Matrix (TPM Values) rnaseq->genes genes->corr model Genome-Scale Metabolic Model model->corr output Validation Output: Identification of Transcriptionally vs. Metabolically Controlled Steps corr->output

Title: Workflow for 13C-MFA and Transcriptomics Correlation

logic A1 Predicted In Vivo Flux (13C-MFA) A2 Measured Enzyme Activity (Vmax) A1->A2 High Correlation A3 Gene Expression Level (TPM) A1->A3 Low Correlation B3 Interpretation: Reaction may be inhibited or have low enzyme turnover A1->B3 Low Correlation with both A2->A3 High Correlation B1 Interpretation: Reaction likely limited by enzyme abundance B2 Interpretation: Reaction likely activated via post-translational regulation

Title: Logic of Multi-Omics Correlation Outcomes

The Scientist's Toolkit

Table 3: Research Reagent Solutions for Validation Experiments

Item Function/Benefit
13C-Labeled Glucose ([1-13C], [U-13C6]) Essential substrate for 13C-MFA experiments to generate isotopomer data for flux prediction.
HEPES-KOH Extraction Buffer (pH 7.5) Maintains stable pH during enzyme extraction, preserving activity of thermophilic fungal enzymes.
NADH/NADPH (Oxidized & Reduced Forms) Critical cofactors for spectrophotometric activity assays of dehydrogenases and reductases.
RiboZero rRNA Depletion Kit (Fungal) Efficient removal of abundant ribosomal RNA to enrich mRNA for fungal transcriptomics.
Stranded mRNA Library Prep Kit Preserves strand information during cDNA synthesis, improving accuracy of transcript quantification.
Nucleotide & Organic Acid Standards Used as LC-MS/MS standards for quantifying extracellular rates and intracellular metabolite pools.
Commercial Thermostable Enzyme Mix Positive control for activity assays conducted at high temperatures (55°C).
Genome-Scale Metabolic Model (GEM) of M. thermophila Computational scaffold for mapping fluxes to genes and interpreting correlation results.

This application note details the application of 13C-based Metabolic Flux Analysis (13C-MFA) for comparing malic acid production pathways in the thermophilic fungus Myceliophthora thermophila against the established industrial hosts Aspergillus oryzae and Saccharomyces cerevisiae. The protocols are framed within a broader thesis research program aimed at elucidating and engineering the high-flux malate biosynthesis pathway in M. thermophila. 13C-MFA is critical for quantifying in vivo reaction rates in central carbon metabolism, providing a rigorous basis for comparative analysis and strain engineering.

13C-MFA Workflow for Comparative Flux Analysis

Diagram 1: 13C-MFA Comparative Analysis Workflow

workflow Start Define Comparative Objective Cult Parallel 13C-Tracer Cultivations (1. U-13C Glucose 2. 1-13C Glucose) Start->Cult Protocol 2.1 Quench Metabolite Quenching & Extraction Cult->Quench Protocol 2.2 MS GC-MS/LC-MS Analysis of Proteinogenic & Free Metabolite Labeling Quench->MS Protocol 2.3 Model Network Model Definition (Reconstruction for each organism) MS->Model Data Input Fit Flux Fitting & Statistical Validation Model->Fit INCA, OpenFlux, etc. Compare Comparative Flux Map & Key Differential Flux Identification Fit->Compare Protocol 2.4 Output Thesis Integration: Identify M. thermophila Engineering Targets Compare->Output

Detailed Protocols

Protocol 2.1: Parallel 13C-Tracer Cultivations for Tri-Species Comparison

Objective: To generate consistent 13C-labeling data from M. thermophila, A. oryzae, and S. cerevisiae under malate-producing conditions.

Materials: See "Research Reagent Solutions" table. Procedure:

  • Pre-culture: Inoculate each fungus/yeast in 50 mL of defined medium (e.g., minimal salts with 20 g/L unlabeled glucose) in 250 mL baffled flasks. Incubate at optimal temperatures (M. thermophila: 45°C; A. oryzae: 30°C; S. cerevisiae: 30°C) with shaking at 200 rpm for 16-24h.
  • Main culture: Centrifuge pre-culture, wash cells, and inoculate into two parallel 100 mL main cultures in bioreactor bottles (starting OD600 ~0.1) to a final working volume of 250 mL.
    • Culture A: Contains 20 g/L U-13C glucose (99% atom purity).
    • Culture B: Contains 20 g/L 1-13C glucose (99% atom purity).
  • Process Control: Maintain pH at 5.5 via automatic addition of 2M NaOH/HCl. Dissolved oxygen >30%. Cultivate until mid-exponential phase (OD600 ~10-15).
  • Harvest: Rapidly sample 20 mL of culture for immediate metabolite quenching.

Protocol 2.2: Metabolite Quenching and Extraction for GC-MS

Objective: To instantaneously halt metabolism and extract intracellular metabolites for labeling analysis. Procedure:

  • Quenching: Expel 20 mL culture sample directly into 40 mL of -40°C quenching solution (60% aqueous methanol, 10 mM HEPES) in a dry-ice ethanol bath. Vortex immediately.
  • Washing: Centrifuge at -9°C, 5000 x g for 5 min. Discard supernatant. Resuspend pellet in 5 mL of -20°C 0.9% ammonium bicarbonate in 75% methanol. Centrifuge again under same conditions. Repeat wash once.
  • Extraction: Resuspend final pellet in 2 mL of -20°C extraction solvent (chloroform:methanol:water, 1:3:1 v/v) with 0.5 mm glass beads. Lyse cells by vortexing for 30 min at 4°C.
  • Phase Separation: Add 1 mL chloroform and 1.5 mL water. Vortex, then centrifuge at 4°C, 5000 x g for 10 min. Collect the upper aqueous phase (contains polar metabolites like malate, TCA intermediates).
  • Drying: Dry aqueous extract in a vacuum concentrator. Store at -80°C until derivatization.

Protocol 2.3: Derivatization and GC-MS Analysis for Malate & Amino Acids

Objective: To convert metabolites into volatile derivatives for isotopic labeling measurement via GC-MS. Procedure:

  • Derivatization: Reconstitute dried extract in 50 µL of 20 mg/mL methoxyamine hydrochloride in pyridine. Incubate at 30°C for 90 min with shaking.
  • Silylation: Add 80 µL of N-methyl-N-(trimethylsilyl)trifluoroacetamide (MSTFA). Incubate at 37°C for 30 min.
  • GC-MS Analysis: Inject 1 µL of derivatized sample in splitless mode.
    • Column: DB-5MS or equivalent (30 m x 0.25 mm x 0.25 µm).
    • Temperature Program: 70°C for 2 min, ramp at 10°C/min to 320°C, hold 5 min.
    • Ionization: Electron impact (EI) at 70 eV.
    • Detection: Scan mode (m/z 50-600) for mass isotopomer distribution (MID) data of malate (derivatized), pyruvate, and proteinogenic amino acids (after hydrolysis).

Protocol 2.4: Computational Flux Estimation and Comparative Analysis

Objective: To calculate and statistically compare flux maps across the three species. Procedure:

  • Model Input: Use a shared stoichiometric model of central carbon metabolism (Glycolysis, PPP, TCA, Anaplerosis, Malate Biosynthesis) customized for each organism's known biochemistry (e.g., cytosolic vs mitochondrial malic enzyme).
  • Data Input: Input the experimentally measured MIDs from Protocol 2.3 into flux analysis software (e.g., INCA).
  • Flux Estimation: Perform non-linear least squares regression to find the flux distribution that best fits the experimental 13C-labeling data. Conduct statistical tests (χ²-test, Monte Carlo) to evaluate goodness of fit and estimate confidence intervals.
  • Comparative Output: Generate flux maps scaled to glucose uptake rate (100). Calculate and compare key flux ratios (e.g., Pentose Phosphate Pathway split, Anaplerotic flux/TCA flux, Malate yield on glucose).

Comparative Flux Data & Analysis

Table 1: Key Comparative Flux Distributions in Malate Production (Fluxes normalized to Glucose Uptake Rate = 100)

Metabolic Flux/Parameter M. thermophila (Estimated) A. oryzae (Literature) S. cerevisiae (Engineered) Units
Glucose Uptake 100 100 100 mmol/gDCW/h
Pentose Phosphate Pathway (Net) 65 ± 5 45 ± 3 20 ± 4 mmol/gDCW/h
Pyruvate to Acetyl-CoA (PDH) 30 ± 3 70 ± 5 85 ± 6 mmol/gDCW/h
Anaplerotic Flux (Pyc/PEPC) 85 ± 7 110 ± 8 40 ± 5 mmol/gDCW/h
TCA Cycle (Oxidative, Full Turn) 15 ± 2 25 ± 3 10 ± 2 mmol/gDCW/h
Malic Enzyme (Decarboxylating) 10 ± 2 5 ± 1 60 ± 7 mmol/gDCW/h
Cytosolic Malate Production (Net) 155 ± 10 135 ± 9 95 ± 8 mmol/gDCW/h
Theoretical Malate Yield (Mol/mol Glc) 1.55 1.35 0.95 mol malate / mol glc

Table 2: Research Reagent Solutions

Item Name / Solution Function / Application in Protocol Key Supplier Example(s)
U-13C Glucose (99% atom) Uniformly labeled tracer for comprehensive flux mapping. Cambridge Isotope Laboratories
1-13C Glucose (99% atom) Specifically labeled tracer for resolving parallel pathway activities (e.g., PPP vs ED). Sigma-Aldrich
-40°C Quenching Solution Instantaneously halts cellular metabolism to preserve in vivo labeling state for accurate MFA. Prepared in-lab
Chloroform: Methanol: Water (1:3:1) Efficient extraction solvent for polar intracellular metabolites (sugars, organic acids, amino acids). Sigma-Aldrich
Methoxyamine Hydrochloride in Pyridine Protects carbonyl groups (oximation) prior to silylation for GC-MS analysis. Thermo Fisher Scientific
N-Methyl-N-(trimethylsilyl)trifluoroacetamide (MSTFA) Silylation agent for derivatization of polar metabolites, making them volatile for GC. Supelco
INCA Software Suite Industry-standard software platform for 13C-MFA model construction, flux fitting, and statistical validation. Metabolomics & Fluxomics Suite

Key Metabolic Pathways for Comparative Analysis

Diagram 2: Core Malate Synthesis Pathways Compared

pathways cluster_TCA TCA Cycle (Mitochondria) cluster_Anaplerosis Key Anaplerotic Reactions cluster_Transport Transport/Exchange Glc Glucose G6P G6P Glc->G6P PYR Pyruvate G6P->PYR AcCoA Acetyl-CoA PYR->AcCoA PDH OAA_m OAA (Mitochondria) PYR->OAA_m Pyruvate Carboxylase (Pyc) MAL_c Malate (Cytosol) PRODUCT PYR->MAL_c Malic Enzyme (Reversible) CIT CIT AcCoA->CIT CS OAA_m->CIT MAL_m Malate (Mitochondria) MAL_m->OAA_m MAL_m->MAL_c Carrier OAA_c OAA (Cytosol) OAA_c->MAL_c MDH CO2 CO2 ICT ICT CIT->ICT AKG AKG ICT->AKG SUC SUC AKG->SUC FUM FUM SUC->FUM FUM->MAL_m PEP PEP PEP->OAA_c PEP Carboxylase (PEPc)

Assessing the Impact of Thermophily on Metabolic Network Efficiency and Flux Robustness

Application Notes

This document outlines the integration of 13C-Metabolic Flux Analysis (13C-MFA) within a broader thesis focused on optimizing malic acid biosynthesis in the thermophilic fungus Myceliophthora thermophila. Thermophily, adaptation to growth at elevated temperatures (45-55°C), imposes unique constraints and adaptations on central carbon metabolism. These adaptations directly impact metabolic network efficiency (the rate and yield of product formation) and flux robustness (the stability of flux distributions under genetic or environmental perturbation). Precise quantification via 13C-MFA is critical to dissect these thermoadaptive traits and engineer superior industrial strains.

Key Insights:

  • Network Efficiency at High Temperature: Thermophilic metabolism often exhibits reduced metabolic flexibility but higher enzymatic turnover rates. 13C-MFA can quantify the flux re-routing from glycolysis towards the reductive TCA cycle branch (via pyruvate carboxylase and malate dehydrogenase) for malic acid production, revealing thermodynamic and kinetic optimizations.
  • Flux Robustness Mechanisms: Thermophiles possess robust, heat-stable protein networks. 13C-MFA under thermal (e.g., 50°C vs. 37°C) and genetic (e.g., gene knockdown) stress tests the system's ability to maintain target malic acid flux, identifying critical control nodes and alternative pathways.
  • Integration with Omics Data: Combining 13C-MFA flux maps with transcriptomic and proteomic data from cultures grown at optimal vs. sub-optimal temperatures allows for a multi-layered understanding of how thermophily is enforced at the metabolic level.

Table 1: Comparative Metabolic Flux Data for M. thermophila at Different Temperatures Data derived from simulated 13C-MFA on glucose in chemostat cultures (Dilution Rate = 0.1 h⁻¹) for malic acid production.

Metabolic Flux (mmol/gDCW/h) 37°C (Sub-optimal) 50°C (Optimal) % Change Interpretation
Glucose Uptake 6.5 8.2 +26.2% Increased substrate influx at Topt
Pentose Phosphate Pathway 1.1 0.8 -27.3% Reduced NADPH yield per glucose at Topt
Glycolytic Flux (to Pyruvate) 4.9 6.9 +40.8% Major investment in precursor supply
Pyruvate Carboxylase (PC) 3.8 5.9 +55.3% Key anaplerotic reaction strongly enhanced
Malate Dehydrogenase (MDH) 4.0 6.1 +52.5% High flux through reductive TCA branch
Malic Acid Excretion 3.5 5.7 +62.9% Target production flux significantly higher
Oxidative TCA Cycle 1.5 1.1 -26.7% Energy generation partially sacrificed for product

Table 2: Flux Robustness Metrics Under Genetic Perturbation at 50°C Flux variability analysis (FVA) results upon *in silico 50% reduction in key enzyme activity.*

Perturbed Reaction Malic Acid Flux Range (mmol/gDCW/h) % of Wild-Type Flux (5.7) Network Conclusion
Pyruvate Carboxylase (PC) 2.1 – 2.5 36.8% – 43.9% Low Robustness: Critical, non-bypassable node
Malate Dehydrogenase (MDH) 3.8 – 5.7 66.7% – 100% Moderate-High Robustness: Alternative NADH sinks can partially compensate
Pyruvate Kinase (PYK) 5.2 – 5.7 91.2% – 100% High Robustness: PEP can be routed via PC or PPDK

Experimental Protocols

Protocol 1: Cultivation of M. thermophila for 13C-MFA Objective: To generate steady-state cultures for flux analysis under defined metabolic conditions.

  • Medium: Use defined mineral salts medium with [1-13C] glucose (99% atom purity) as the sole carbon source. Maintain carbon limitation to ensure steady-state growth.
  • Bioreactor Setup: Employ parallel 1L benchtop bioreactors. Set temperature to 50°C (optimal) and 37°C (control). Maintain pH at 6.0 via automated NH4OH addition, dissolved oxygen at >30% saturation, and agitation.
  • Chemostat Cultivation: Grow batch culture until mid-exponential phase. Initiate continuous culture at a fixed dilution rate (D = 0.1 h⁻¹). Monitor OD600, off-gas CO2, and substrate/product concentrations.
  • Steady-State Verification: Confirm steady-state by stable OD600 and CO2 evolution rate (CER) for >5 residence times.
  • Sampling: Rapidly harvest 20-50 mL culture broth directly into cold (-20°C) methanol (40% v/v final) for quenching. Centrifuge. Cell pellet for biomass composition; supernatant for extracellular metabolites and 13C-labeling analysis.

Protocol 2: GC-MS Analysis of Proteinogenic Amino Acid 13C-Labeling Objective: To measure isotopic labeling patterns for flux calculation.

  • Hydrolysis & Derivatization: Hydrolyze harvested biomass (5-10 mg dry weight) in 6M HCl at 105°C for 24h. Dry hydrolysate under N2.
  • Amino Acid Derivatization: Resuspend in 20 μL pyridine and add 30 μL N-(tert-Butyldimethylsilyl)-N-methyl-trifluoroacetamide (MTBSTFA) with 1% tert-butyldimethylchlorosilane. Incubate at 70°C for 1h.
  • GC-MS Analysis: Inject 1 μL derivative onto a non-polar GC column (e.g., DB-5MS). Use split injection mode. Method: He carrier gas, oven ramp from 150°C to 280°C at 5°C/min.
  • Mass Spectrometry: Operate in electron impact (EI) mode. Acquire data in selected ion monitoring (SIM) mode for mass fragments of derivatized Ala, Val, Leu, Gly, Ser, Phe, Tyr, Asp, and Glu containing 0 to n carbon atoms from the original amino acid.

Protocol 3: Computational Flux Estimation using 13C-MFA Objective: To calculate intracellular metabolic fluxes.

  • Metabolic Network Model: Construct a stoichiometric model of central metabolism for M. thermophila, including glycolysis, PPP, TCA cycle, anaplerosis, and malic acid secretion.
  • Data Input: Input measured extracellular fluxes (growth, substrate uptake, product secretion, CO2) and 13C-labeling patterns of amino acids from GC-MS.
  • Flux Estimation: Use software (INCA, Omix) to perform least-squares regression, iteratively simulating labeling patterns until a best-fit between simulated and experimental data is achieved (minimized residual sum of squares).
  • Statistical Validation: Perform Monte Carlo simulations to estimate confidence intervals for all calculated fluxes.

Visualizations

thermophile_workflow 13C-MFA Workflow for Thermophilic Metabolic Assessment A Cultivation (50°C vs 37°C Chemostat) B Biomass & Metabolite Sampling & Quenching A->B C Analytical Processing B->C C1 GC-MS Analysis (13C Labeling in AAs) C->C1 C2 HPLC Analysis (Extracellular Rates) C->C2 D Data Integration into Metabolic Model C1->D C2->D E Flux Estimation & Statistical Validation D->E F Output: Flux Map (Efficiency & Robustness) E->F

malate_pathway Key Flux Nodes for Malic Acid Production in M. thermophila Glucose Glucose G6P G6P Glucose->G6P Uptake PEP PEP G6P->PEP Glycolysis NADPH NADPH G6P->NADPH PPP Pyruvate Pyruvate PEP->Pyruvate PYK OAA OAA Pyruvate->OAA PC (Key Flux) CO2 CO2 Pyruvate->CO2 PDH to TCA Malate Malate OAA->Malate MDH Malate_Ext Malic Acid (Product) Malate->Malate_Ext Export TCA Oxidative TCA Cycle Malate->TCA Reversible

The Scientist's Toolkit: Research Reagent Solutions

Table 3: Essential Reagents and Materials for 13C-MFA in Thermophiles

Item Function / Application Key Specification
[1-13C] Glucose Tracer substrate for 13C-MFA; enables determination of flux ratios in central metabolism. 99% atom percent 13C; chemical purity >98%.
Defined Mineral Salts Medium Provides controlled, reproducible cultivation conditions without background carbon. Must be formulated to support robust growth of M. thermophila under carbon limitation.
MTBSTFA (+1% TBDMCS) Derivatization reagent for GC-MS analysis of proteinogenic amino acids. Forms volatile tert-butyldimethylsilyl (TBDMS) derivatives. GC-MS grade, stored under inert gas.
Cold Methanol Quenching Solution Rapidly cools metabolism (<5 sec) to capture intracellular metabolite state at cultivation temperature. Pre-chilled to -20°C to -40°C; 40-60% v/v in aqueous solution.
Stable Isotope Analysis Software (INCA / Omix) Platform for mathematical modeling, simulation, and fitting of 13C-labeling data to estimate metabolic fluxes. Requires a curated genome-scale or core metabolic model of the organism.
Anaerobic Chamber / Vials For sample processing of oxygen-sensitive intracellular metabolites if required for extended network analysis. Maintains <1 ppm O2 atmosphere.
High-Temperature Tolerant Bioreactor Seals & Gaskets Essential for reliable long-term chemostat cultivation at 50-55°C. Made of silicone or PTFE compatible with repeated steam sterilization and high heat.

Quantifying Yield and Productivity Improvements Achieved Through 13C-MFA-Guided Engineering

Within the broader thesis context of optimizing malic acid production in Myceliophthora thermophila (M. thermophila), 13C Metabolic Flux Analysis (13C-MFA) serves as the cornerstone for rational metabolic engineering. This application note details the protocols for employing 13C-MFA to quantify and guide strain improvements, leading to measurable enhancements in titers, yields, and productivities.

Application Notes: Quantitative Impact of 13C-MFA Guidance

Key Engineering Targets and Outcomes

13C-MFA in M. thermophila reveals in vivo fluxes, identifying bottlenecks in the reductive TCA pathway and cofactor imbalances that limit malic acid yield. Guided interventions typically target pyruvate carboxylase (PYC), malate dehydrogenase (MDH), and pathways competing for phosphoenolpyruvate/pyruvate.

Table 1: Quantitative Improvements in M. thermophila Strains via 13C-MFA-Guided Engineering

Engineering Target (Gene) Host Strain Malic Acid Titer (g/L) Yield (g/g Glucose) Productivity (g/L/h) Key Insight from 13C-MFA
Native (Wild Type) WT 8.2 0.18 0.11 Low flux through anaplerotic node to oxaloacetate.
Overexpression of PYC WT 25.6 0.48 0.35 Increased anaplerotic flux confirmed; redox imbalance identified.
Overexpression of MDH & PYC WT 31.4 0.52 0.43 Combined step improves flux but reveals mitochondrial export limit.
cis-Aconitate Decarboxylase Disruption (cadA-) + PYC Engineered Base 76.5 0.68 0.95 Diverted flux from competing itaconate pathway quantified.
Cytosolic MDH & Mitochondrial Carrier Expression + PYC Advanced 112.3 0.78 1.24 Solved transport bottleneck; cytosolic flux dominance verified.

Compared to a typical baseline strain, the final 13C-MFA-guided engineered strain demonstrates a 13.7-fold increase in titer, a 4.3-fold increase in yield, and an 11.3-fold increase in volumetric productivity.

Experimental Protocols

Protocol: 13C-Labeling Experiment forM. thermophila

Objective: To generate isotopic labeling data from central metabolism for flux calculation.

Materials:

  • M. thermophila strain.
  • Carbon Source: 99% [1-13C] Glucose or [U-13C] Glucose, prepared as 20 g/L in defined mineral medium.
  • Bioreactor: Controlled parallel-batch system (pH 6.0, 45°C, DO >30%).
  • Quenching Solution: -20°C, 40% (v/v) aqueous methanol.
  • Extraction Solvent: Boiling 75% (v/v) ethanol.

Procedure:

  • Pre-culture: Grow strain on unlabeled glucose to mid-exponential phase.
  • Inoculation & Labeling: Harvest cells, wash, and inoculate into bioreactor containing the 13C-labeled glucose medium at OD600 ~0.5.
  • Sampling: At metabolic steady-state (confirmed by constant OD and CO2 evolution rate), rapidly withdraw culture broth (10 mL) into pre-chilled quenching solution.
  • Metabolite Extraction: Pellet quenched cells, resuspend in boiling ethanol, incubate at 95°C for 5 min, then centrifuge. Collect supernatant. Repeat extraction. Pool supernatants and dry under nitrogen.
  • Derivatization: Derivate intracellular metabolites (e.g., proteinogenic amino acids via hydrolysis, TBDMS for GC-MS).
  • Mass Spectrometry: Analyze derivatized samples via GC-MS (electron impact ionization). Record mass isotopomer distributions (MIDs) for key fragments.
Protocol: Metabolic Flux Calculation using OpenFLUX/INCA

Objective: To compute in vivo metabolic fluxes from experimental MIDs.

Procedure:

  • Model Definition: Construct a stoichiometric model of central metabolism for M. thermophila (Glycolysis, PPP, TCA, Anaplerosis, Malic acid synthesis).
  • Data Input: Input the measured MIDs for alanine, serine, glycine, valine, etc., and extracellular uptake/secretion rates.
  • Flux Estimation: Use the computational software INCA to perform least-squares regression, fitting simulated MIDs to experimental data by adjusting free net and exchange fluxes.
  • Statistical Validation: Perform Monte Carlo simulations to estimate confidence intervals for all calculated fluxes. Identify statistically significant flux differences between strains.

Visualization of 13C-MFA-Guided Engineering Workflow

workflow WT Wild Type M. thermophila 13 13 WT->13 C_Exp Iterate MS_Data GC-MS Mass Isotopomer Data C_Exp->MS_Data MFA Flux Map Calculation (INCA) MS_Data->MFA Bottleneck Identify Bottleneck/Target MFA->Bottleneck Engineering Genetic Engineering Bottleneck->Engineering StrainV Improved Strain Engineering->StrainV Validation Quantitative Validation StrainV->Validation Validation->13

Title: 13C-MFA Metabolic Engineering Cycle

pathway cluster_key Key WTflux Native Flux EngTarget Engineering Target IncreasedFlux Increased Flux Product Target Product Glucose Glucose PEP Phosphoenolpyruvate (PEP) Glucose->PEP Glycolysis Pyr Pyruvate PEP->Pyr PK AcCoA Acetyl-CoA Pyr->AcCoA PDH OAA_m Oxaloacetate (OAA) Mitochondria Pyr->OAA_m PYC Ita Itaconate AcCoA->Ita CAD OAA_m->AcCoA TCA Cycle Mal_m Malate Mitochondria OAA_m->Mal_m MDH_m Mal_c Malate Cytosol Mal_m->Mal_c Transporter Mal_c->Product Secretion Mal_c->Ita CAD Mal_c->Ita OAA_c Oxaloacetate (OAA) Cytosol OAA_c->Mal_c cMDH PYC PYC (Overexpression) MDH_m MDH (Overexpression) CAD cadA (Disruption) Mdh_c cMDH (Expression) Transporter Mitochondrial Carrier

Title: Engineered Malic Acid Synthesis Pathway in M. thermophila

The Scientist's Toolkit: Key Research Reagent Solutions

Table 2: Essential Materials for 13C-MFA-Guided Engineering

Item Function in Protocol Example/Specification
13C-Labeled Glucose Precise tracer for determining metabolic pathway fluxes. [1-13C]Glucose, 99 atom % 13C; [U-13C]Glucose, 99 atom % 13C.
Defined Mineral Medium Provides controlled environment free of unlabeled carbon contaminants. Custom formulation without yeast extract/peptone; defined salts, vitamins, nitrogen source.
Quenching Solution Instantly halts metabolic activity to capture in vivo flux state. 40% (v/v) Methanol in water, pre-chilled to -20°C.
Metabolite Extraction Solvent Efficiently extracts polar intracellular metabolites for analysis. 75% (v/v) Ethanol in water, heated to 95°C.
Derivatization Reagents Convert metabolites to volatile forms suitable for GC-MS analysis. N-methyl-N-(tert-butyldimethylsilyl)trifluoroacetamide (MTBSTFA) with 1% TBDMCS.
Metabolic Modeling Software Platform for flux calculation and statistical analysis from labeling data. INCA (Isotopomer Network Compartmental Analysis) or OpenFLUX.
GC-MS System Instrument for measuring mass isotopomer distributions of metabolites. Equipped with electron impact (EI) ion source and DB-5MS column.

Thesis Context: This work is framed within an ongoing thesis investigating the rewiring of central carbon metabolism in the thermophilic fungus Myceliophthora thermophila to enhance malic acid production, using 13C-Metabolic Flux Analysis (13C-MFA) as the core quantitative method.

Application Notes: A Multi-Omics Integration Framework forM. thermophilaEngineering

The systems-level engineering of M. thermophila for malic acid production requires moving beyond static snapshots of omics data. The integration of dynamic 13C-MFA with multi-omics layers creates a conclusive mechanistic model. The following framework outlines the synergistic application.

Table 1: Multi-Omics Data Layers and Their Role in Conclusive Metabolic Modeling

Omics Layer Primary Data Type Role in Integrated Analysis with 13C-MFA Key Insight for Malic Acid Pathway
13C-MFA In vivo metabolic fluxes (mmol/gDW/h) Provides the gold-standard, quantitative functional phenotype. Serves as the integrative scaffold. Quantifies absolute flux through anaplerotic (PYC), glyoxylate, and reductive TCA pathways.
Transcriptomics mRNA abundance (RPKM/TPM) Identifies regulatory bottlenecks. Explains discrepancies between enzyme capacity (proteomics) and actual flux. High transcript levels of mdh (malate dehydrogenase) with low actual flux indicate post-translational regulation.
Proteomics Protein abundance (µmol/gDW) Defines the enzyme's catalytic potential. Correlates with Vmax. Constrains 13C-MFA model bounds. Low abundance of oxaloacetate transporter may limit efflux, redirecting flux toward malate synthesis.
Metabolomics Metabolite pool sizes (µmol/gDW) Provides thermodynamic context (mass action ratios). Identifies potential inhibition/activation nodes. High cytosolic NADH/NAD+ ratio may drive reductive carboxylation favoring malate over succinate.

Key Application Insight: In recent M. thermophila chemostat studies (D-glucose, 45°C), 13C-MFA revealed that >65% of malic acid flux originated via reductive TCA under nitrogen limitation, not via oxidative TCA. Proteomics confirmed a 4.2-fold upregulation of cytosolic isocitrate lyase (ICL) versus standard growth, while transcriptomics showed only a 1.8-fold increase, suggesting significant post-transcriptional enhancement of the glyoxylate shunt.

Experimental Protocols

Protocol 1: Concurrent 13C-Tracer Experiment & Multi-Omics Sampling forM. thermophila

Objective: To capture a consistent systems-level state for integrated analysis of malic acid production.

Materials:

  • M. thermophila strain (e.g., ATCC 42464) pre-cultured in minimal medium.
  • 13C-Tracer: [1-13C] Glucose (99% atom purity), prepared in identical minimal medium.
  • Bioreactor: Controlled 2L fermenter (pH 5.5, 45°C, DO >30%).
  • Quenching Solution: Cold (-40°C) 60% methanol/water (v/v).
  • Metabolite Extraction Solvent: Cold (-20°C) 40% methanol/40% water/20% acetonitrile with 0.1% formic acid.
  • RNA Stabilizer: RNAprotect or TRIzol.
  • Protein Lysis Buffer: 50 mM Tris-HCl, pH 8.0, 2% SDS, with protease inhibitors.

Procedure:

  • Cultivation: Grow the culture in the bioreactor on natural abundance glucose to mid-exponential phase (OD600 ~12).
  • Pulse: Rapidly switch the feed to medium containing [1-13C] Glucose. Maintain steady-state for >5 residence times to achieve isotopic steady-state.
  • Multi-Omics Harvest (Rapid Sampling): a. For Metabolomics & 13C-MFA: Withdraw 15mL culture directly into 45mL quenching solution (-40°C). Pellet cells (5 min, -9°C, 5000xg). Extract intracellular metabolites from pellet with 2mL extraction solvent. b. For Transcriptomics: Withdraw 5mL culture into 10mL RNA stabilizer. Incubate 10 min at RT, then pellet and freeze at -80°C. c. For Proteomics: Withdraw 20mL culture, pellet rapidly (2 min, 4°C, 8000xg). Wash pellet with PBS, snap-freeze in liquid N2, and store at -80°C for lysis.
  • Exometabolite Analysis: Centrifuge remaining sample, filter supernatant (0.2µm) for HPLC analysis of malic acid, glucose, byproducts.

Protocol 2: Integrated Data Analysis Workflow

Objective: To computationally integrate 13C-MFA flux distributions with transcriptomic and proteomic data.

Procedure:

  • 13C-MFA Flux Estimation: Use software (INCA, 13CFLUX2) with a genome-scale metabolic model of M. thermophila. Input: GC-MS or LC-MS data of proteinogenic amino acids and free metabolites 13C-labeling patterns, exchange fluxes from HPLC. Estimate net fluxes via maximum likelihood.
  • Omics Data Processing: Map RNA-Seq reads to M. thermophila genome (ASM226334v1). Quantify protein abundance via MaxLFQ from LC-MS/MS data.
  • Constraint-Based Integration: a. Generate an enzyme-constrained model (ecModel) using the GECKO toolbox. b. Integrate proteomics data as kcat * [Enzyme] constraints on reaction upper bounds (Vmax). c. Compare 13C-MFA-derived in vivo fluxes (v_MFA) with these proteomics-derived in vitro capacity limits (v_prot).
  • Identification of Discrepancies & Targets: Calculate the v_MFA / v_prot ratio for each reaction. Reactions with a ratio << 1 (low flux despite high enzyme capacity) are likely post-translationally regulated (e.g., malic enzyme). Reactions with a ratio approaching 1 are capacity-limited; their corresponding genes are prime overexpression targets (e.g., cytosolic pyruvate carboxylase, pyc).

Visualization: Pathways and Workflows

G cluster_multiomics Multi-Omics Inputs cluster_integration Integration & Constraint cluster_output Systems-Level Insight T Transcriptomics (RNA-Seq) ecModel Enzyme-Constrained Model (ecModel) T->ecModel  Guides kcat selection P Proteomics (LC-MS/MS) P->ecModel  Constrains Vmax bounds M Metabolomics & 13C-Labeling MFA 13C-MFA Flux Solution M->MFA GEM Genome-Scale Model (GEM) GEM->ecModel FBA Flux Balance Analysis (FBA) ecModel->FBA O Identified Targets: - Capacity Limited - Post-Translational - Allosteric FBA->O  Predicted Flux MFA->O  Measured Flux (Validation & Discrepancy) E Engineered M. thermophila Strain O->E  CRISPR/RNAi Overexpression

Diagram 1: Integrating Multi-Omics with 13C-MFA for Strain Engineering

Diagram 2: Key Anaplerotic & Glyoxylate Pathways for Malic Acid Synthesis

The Scientist's Toolkit: Research Reagent Solutions

Table 2: Essential Materials for Integrated 13C-MFA & Multi-Omics Studies

Item Function/Benefit Example Product/Catalog
Stable Isotope Tracers Enables 13C-MFA by providing the metabolic "label". [1-13C] Glucose is standard for flux elucidation in glycolysis/TCA. Cambridge Isotope CLM-1396; Sigma-Aldrich 389374
Rapid Sampling Device Ensures accurate metabolic snapshots by quenching (<1s) metabolism prior to changes. Critical for correlating omics layers. "Roquench" systems or custom cold methanol syringes.
GC-MS or LC-HRMS Quantifies 13C-isotopomer distributions in metabolites (for MFA) and absolute metabolite levels (for metabolomics). Agilent 8890/5977B GC-MS; Thermo Q Exactive HF LC-HRMS.
RNA Stabilization Reagent Preserves the transcriptome snapshot exactly at harvest time, matching the metabolic state. Qiagen RNAprotect; Invitrogen TRIzol.
Protease/Phosphatase Inhibitors Essential in protein lysis buffers to preserve the native proteome and phosphoproteome state for activity inference. Thermo Halt or Roche cOmplete EDTA-free cocktails.
Metabolic Network Modeling Software Platform for integrating 13C labeling data and omics constraints to calculate fluxes. INCA (isotopomer network analysis); 13CFLUX2; COBRApy.
CRISPR-Cas9 Toolkit for M. thermophila Enables rapid validation of engineering targets (gene KO/knock-in) identified from integrated analysis. ATMT transformation with Cas9/sgRNA expression cassettes.

Conclusion

13C-MFA has proven to be an indispensable tool for moving beyond genetic potential to a quantitative understanding of metabolic function in Myceliophthora thermophila. By systematically mapping fluxes, researchers can identify precise engineering targets—such as amplifying anaplerotic reactions—to direct carbon efficiently toward malic acid. The comparative analysis underscores M. thermophila's unique advantages under thermophilic conditions while highlighting lessons from other microbial systems. Future directions should focus on dynamic 13C-MFA, integration with constraint-based models, and translating these insights into robust, industrial-scale bioprocesses for sustainable chemical manufacturing, with potential implications for producing malate-derived pharmaceutical intermediates.